nwfl-20200930x10q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission file number 0-28364

Norwood Financial Corp

(Exact name of registrant as specified in its charter)


Pennsylvania		23-2828306
(State or other jurisdiction of incorporation or organization)		(I.R.S. employer identification no.)

717 Main Street, Honesdale, Pennsylvania		18431
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (570) 253-1455

N/A

Former name, former address and former fiscal year, if changed since last report.

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.10 per share	NWFL	The Nasdaq Stock Market LLC

Indicate by check (x) whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	☐	Accelerated filer	☒
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): ☐ Yes ☒ No

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.


Class		Outstanding as of November 1, 2020
Common stock, par value $0.10 per share		8,201,128

NORWOOD FINANCIAL CORP.

FORM 10-Q

FOR THE QUARTER ENDED SEPTEMBER 30, 2020


		Page Number

PART I -	CONSOLIDATED FINANCIAL INFORMATION OF NORWOOD FINANCIAL CORP.	3

Item 1.	Financial Statements (unaudited)	3
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	35
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	47
Item 4.	Controls and Procedures	49

PART II -	OTHER INFORMATION	49

Item 1.	Legal Proceedings	49
Item 1A.	Risk Factors	49
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	50
Item 3.	Defaults Upon Senior Securities	50
Item 4.	Mine Safety Disclosures	50
Item 5.	Other Information	50
Item 6.	Exhibits	51

Signatures		53

‎

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NORWOOD FINANCIAL CORP

Consolidated Balance Sheets (unaudited)

(dollars in thousands, except share and per share data)



	September 30,		December 31,
	2020		2019
ASSETS
Cash and due from banks	$	23,874	$	15,038
Interest-bearing deposits with banks		100,566		377
Cash and cash equivalents		124,440		15,415
Securities available for sale, at fair value		197,436		210,205
Loans receivable		1,414,662		924,581
Less: Allowance for loan losses		11,674		8,509
Net loans receivable		1,402,988		916,072
Regulatory stock, at cost		3,876		4,844
Bank premises and equipment, net		18,124		14,228
Bank owned life insurance		39,400		38,763
Accrued interest receivable		6,104		3,719
Foreclosed real estate owned		965		1,556
Goodwill		30,213		11,331
Other intangibles		565		235
Other assets		17,996		14,242
TOTAL ASSETS	$	1,842,107	$	1,230,610
LIABILITIES
Deposits:
Non-interest bearing demand	$	372,237	$	207,299
Interest-bearing		1,143,685		750,230
Total deposits		1,515,922		957,529
Short-term borrowings		69,294		62,256
Other borrowings		46,438		56,438
Accrued interest payable		2,194		2,432
Other liabilities		17,712		14,527
TOTAL LIABILITIES		1,651,560		1,093,182
STOCKHOLDERS’ EQUITY
Preferred stock, no par value per share,
authorized: 5,000,000 shares; issued: none		—		—
Common stock, $0.10 par value per share,
authorized: 20,000,000 shares,
issued: 2020: 8,210,982 shares, 2019: 6,340,563 shares		821		634
Surplus		95,108		49,471
Retained earnings		90,422		86,536
Treasury stock at cost: 2020: 13,778 shares; 2019: 12,007 shares		(469)		(400)
Accumulated other comprehensive income		4,665		1,187
TOTAL STOCKHOLDERS’ EQUITY		190,547		137,428
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	1,842,107	$	1,230,610

See accompanying notes to the unaudited consolidated financial statements.
‎

NORWOOD FINANCIAL CORP

Consolidated Statements of Income (unaudited)

(dollars in thousan ds, except per share data)


	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2020		2019		2020		2019
INTEREST INCOME
Loans receivable, including fees	$	16,260	$	10,776	$	37,711	$	31,074
Securities		1,031		1,278		3,272		4,155
Other		18		5		43		70
Total interest income		17,309		12,059		41,026		35,299
INTEREST EXPENSE
Deposits		1,676		1,787		5,096		5,355
Short-term borrowings		61		135		244		344
Other borrowings		242		246		824		827
Total interest expense		1,979		2,168		6,164		6,526
NET INTEREST INCOME		15,330		9,891		34,862		28,773
PROVISION FOR LOAN LOSSES		1,850		300		3,850		1,050
NET INTEREST INCOME AFTER
PROVISION FOR LOAN LOSSES		13,480		9,591		31,012		27,723
OTHER INCOME
Service charges and fees		1,301		1,200		3,201		3,283
Income from fiduciary activities		205		167		533		454
Net realized gains on sales of securities		33		169		71		233
Gain on sale of loans, net		164		15		285		125
Earnings and proceeds on bank owned life insurance		217		222		638		630
Other		152		109		391		358
Total other income		2,072		1,882		5,119		5,083
OTHER EXPENSES
Salaries and employee benefits		4,812		3,667		11,878		10,915
Occupancy, furniture & equipment, net		1,109		916		2,983		2,780
Data processing and related operations		746		480		1,649		1,400
Taxes, other than income		214		179		641		520
Professional fees		292		276		735		752
Federal Deposit Insurance Corporation insurance		144		(5)		186		150
Foreclosed real estate		31		24		44		37
Amortization of intangibles		35		23		79		79
Merger related		386		—		1,983		—
Other		1,611		1,231		4,353		3,591
Total other expenses		9,380		6,791		24,531		20,224
INCOME BEFORE INCOME TAXES		6,172		4,682		11,600		12,582
INCOME TAX EXPENSE		1,173		775		2,033		1,963
NET INCOME	$	4,999	$	3,907	$	9,567	$	10,619
BASIC EARNINGS PER SHARE	$	0.62	$	0.62	$	1.39	$	1.70
DILUTED EARNINGS PER SHARE	$	0.62	$	0.62	$	1.39	$	1.68

See accompanying notes to the unaudited consolidated financial statements.

‎

NORWOOD FINANCIAL CORP

Consolidated Statements of Comprehensive Income (unaudited)

(dollars in thousands)



	Three Months Ended
	September 30,
	2020		2019
Net income	$	4,999	$	3,907
Other comprehensive income:
Investment securities available for sale:
Unrealized holding gain (loss)		(115)		1,059
Tax effect		24		(224)
Reclassification of investment securities gains
recognized in net income		(33)		(169)
Tax effect		7		37
Other comprehensive (loss) income		(117)		703
Comprehensive Income	$	4,882	$	4,610



	Nine Months Ended
	September 30,
	2020		2019
Net income	$	9,567	$	10,619
Other comprehensive income
Investment securities available for sale:
Unrealized holding gain		4,474		8,034
Tax effect		(940)		(1,688)
Reclassification of investment securities gains
recognized in net income		(71)		(233)
Tax effect		15		50
Other comprehensive income		3,478		6,163
Comprehensive Income	$	13,045	$	16,782

See accompanying notes to the unaudited consolidated financial statements.

‎

NORWOOD FINANCIAL CORP

Consolidated Statements of Changes in Stockholders’ Equity (unaudited)

Nine Months Ended September 30, 2020 and 2019

(dollars in thousands, except share and per share data)



													Accumulated
													Other
	Common Stock						Retained		Treasury Stock				Comprehensive
	Shares		Amount		Surplus		Earnings		Shares		Amount		Income		Total
Balance, December 31, 2019		6,340,563	$	634	$	49,471	$	86,536		12,007	$	(400)	$	1,187	$	137,428
Net Income		-		-		-		9,567		-		-		-		9,567
Other comprehensive income		-		-		-		-		-		-		3,478		3,478
Cash dividends declared ($0.75 per share)		-		-		-		(5,681)		-		-		-		(5,681)
Acquisition of UpState New York Bancorp, Inc.		1,865,738		186		45,151		-		-		-		-		45,337
Acquisition of treasury stock		-		-		-		-		1,771		(69)		-		(69)
Compensation expense related to restricted stock		-		-		250		-		-		-		-		250
Stock options exercised		4,681		1		83		-		-		-		-		84
Compensation expense related to stock options		-		-		153		-		-		-		-		153
Balance, September 30, 2020		8,210,982	$	821	$	95,108	$	90,422		13,778	$	(469)	$	4,665	$	190,547


													Accumulated
													Other
	Common Stock						Retained		Treasury Stock				Comprehensive
	Shares		Amount		Surplus		Earnings		Shares		Amount		Income		Total
Balance, December 31, 2018		6,295,113	$	630	$	48,322	$	78,434		2,470	$	(81)	$	(5,020)	$	122,285
Net Income		-		-		-		10,619		-		-		-		10,619
Other comprehensive loss		-		-		-		-		-		-		6,163		6,163
Cash dividends declared ($0.72 per share)		-		-		-		(4,531)		-		-		-		(4,531)
Compensation expense related to restricted stock		-		-		217		-		-		-		-		217
Acquisition of treasury stock		-		-		-		-		11,337		(374)		-		(374)
Stock options exercised		19,575		2		357		-		-		-		-		359
Compensation expense related to stock options		-		-		156		-		-		-		-		156
Balance, September 30, 2019		6,314,688	$	632	$	49,052	$	84,522		13,807	$	(455)	$	1,143	$	134,894

‎

NORWOOD FINANCIAL CORP

Consolidated Statements of Changes in Stockholders’ Equity (unaudited)

Three Months Ended September 30, 2020 and 2019

(dollars in thousands, except share and per share data)



													Accumulated
													Other
	Common Stock						Retained		Treasury Stock				Comprehensive
	Shares		Amount		Surplus		Earnings		Shares		Amount		Income (Loss)		Total
Balance, June 30, 2020		6,342,568	$	634	$	49,778	$	87,939		13,778	$	(469)	$	4,782	$	142,664
Net Income		-		-		-		4,999		-		-		-		4,999
Other comprehensive loss		-		-		-		-		-		-		(117)		(117)
Cash dividends declared ($0.25 per share)		-		-		-		(2,516)		-		-		-		(2,516)
Acquisition of UpState New York Bancorp, Inc.		1,865,738		186		45,151		-		-		-		-		45,337
Compensation expense related to restricted stock		-		-		83		-		-		-		-		83
Stock options exercised		2,676		1		45		-		-		-		-		46
Compensation expense related to stock options		-		-		51		-		-		-		-		51
Balance, September 30, 2020		8,210,982	$	821	$	95,108	$	90,422		13,778	$	(469)	$	4,665	$	190,547


													Accumulated
													Other
	Common Stock						Retained		Treasury Stock				Comprehensive
	Shares		Amount		Surplus		Earnings		Shares		Amount		Income		Total
Balance, June 30, 2019		6,304,413	$	630	$	48,741	$	82,127		13,807	$	(455)	$	440	$	131,483
Net Income		-		-		-		3,907		-		-		-		3,907
Other comprehensive income		-		-		-		-		-		-		703		703
Cash dividends declared ($0.24 per share)		-		-		-		(1,512)		-		-		-		(1,512)
Compensation expense related to restricted stock		-		-		72		-		-		-		-		72
Stock options exercised		10,275		2		187		-		-		-		-		189
Compensation expense related to stock options		-		-		52		-		-		-		-		52
Balance, September 30, 2019		6,314,688	$	632	$	49,052	$	84,522		13,807	$	(455)	$	1,143	$	134,894

See accompanying notes to the unaudited consolidated financial statements.

‎

NORWOOD FINANCIAL CORP

Consolidated Statements of Cash Flows (Unaudited)



(dollars in thousands)
	Nine Months Ended September 30,
	2020		2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income	$	9,567	$	10,619
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for loan losses		3,850		1,050
Depreciation		953		739
Amortization of intangible assets		79		79
Deferred income taxes		(418)		(176)
Net amortization of securities premiums and discounts		933		1,104
Net realized gain on sales of securities		(71)		(232)
Earnings and proceeds on life insurance policies		(638)		(630)
Gain on sales and write-downs of fixed assets and foreclosed real estate owned, net		(22)		(67)
Net gain on sale of loans		(285)		(125)
Loans originated for sale		(7,163)		(2,767)
Proceeds from sale of loans originated for sale		7,402		2,846
Compensation expense related to stock options		153		156
Compensation expense related to restricted stock		250		217
(Increase) decrease in accrued interest receivable		(959)		50
(Decrease) increase in accrued interest payable		(413)		817
Other, net		(4,198)		1,017
Net cash provided by operating activities		9,020		14,697
CASH FLOWS FROM INVESTING ACTIVITIES
Securities available for sale:
Proceeds from sales		24,497		22,862
Proceeds from maturities and principal reductions on mortgage-backed securities		42,806		21,211
Purchases		(37,132)		(5,066)
Purchase of regulatory stock		(3,350)		(2,963)
Redemption of regulatory stock		6,781		3,752
Net increase in loans		(84,990)		(57,891)
Purchase of premises and equipment		(539)		(1,056)
Proceeds from sales of foreclosed real estate owned		611		312
Proceeds from sales of bank premises and equipment		10		246
Acquisition, net of cash and cash equivalents acquired		15,193		—
Net cash used in investing activities		(36,113)		(18,593)
CASH FLOWS FROM FINANCING ACTIVITIES
Net increase in deposits		144,280		27,653
Net increase (decrease) in short-term borrowings		7,038		(268)
Repayments of other borrowings		(20,001)		(22,378)
Proceeds from other borrowings		10,000		6,000
Stock options exercised		84		359
Purchase of treasury stock		(69)		(374)
Cash dividends paid		(5,214)		(4,529)
Net cash provided by financing activities		136,118		6,463
Increase in cash and cash equivalents		109,025		2,567
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		15,415		18,348
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	124,440	$	20,915

‎

NORWOOD FINANCIAL CORP

Consolidated Statements of Cash Flows (Unaudited) (continued)


(dollars in thousands)
	Nine Months Ended September 30,
	2020		2019
Supplemental Disclosures of Cash Flow Information
Cash payments for:
Interest on deposits and borrowings	$	6,402	$	5,709
Income taxes paid, net of refunds	$	1,018	$	1,447
Supplemental Schedule of Noncash Investing Activities:
Transfers of loans to foreclosed real estate and repossession of other assets	$	393	$	1,478
Dividends payable	$	2,049	$	1,512





Merger with UpState New York Bancorp, Inc.
Noncash assets acquired:
Securities available-for-sale	$	13,948
Regulatory stock		2,487
Loans		413,535
Premises and equipment, net		5,529
Accrued interest receivable		1,426
Deferred tax assets		1,495
Other assets		376
		438,796
Liabilities assumed:
Time deposits		204,440
Deposits other than time deposits		206,919
Accrued interest payable		175
Other liabilities		6,496
		418,030
Net Noncash Assets Acquired		20,766
Cash Acquired	$	24,037

See accompanying notes to the unaudited consolidated financial statements.

‎

Notes to the Unaudited Consolidated Financial Statements

1. Basis of Presentation

The unaudited consolidated financial statements include the accounts of Norwood Financial Corp (the “Company”) and its wholly-owned subsidiary, Wayne Bank (the “Bank”) and the Bank’s wholly-owned subsidiaries, WCB Realty Corp., Norwood Investment Corp., and WTRO Properties, Inc. All significant intercompany accounts and transactions have been eliminated in consolidation.

The accompanying unaudited consolidated financial statements have been prepared in conformity with generally accepted accounting principles for interim financial statements and with instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In preparing the financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the balance sheet and revenues and expenses for the period. Actual results could differ from those estimates. The financial statements reflect, in the opinion of management, all normal, recurring adjustments necessary to present fairly the consolidated financial position and results of operations of the Company. The operating results for the three-month and nine-month periods ended September 30, 2020 are not necessarily indicative of the results that may be expected for the year ending December 31, 2020 or any other future interim period.

2. Revenue Recognition

Under ASC Topic 606, management determined that the primary sources of revenue emanating from interest and dividend income on loans and investments along with noninterest revenue resulting from investment security gains, loan servicing, gains on the sale of loans sold and earnings on bank-owned life insurance are not within the scope of this Topic.

The following presents noninterest income, segregated by revenue streams in-scope and out-of-scope of Topic 606, for the three and nine months ended September 30:



	Three months ended
	September 30,
(dollars in thousands)
Noninterest Income	2020		2019
In-scope of Topic 606:
Service charges on deposit accounts	$	93	$	72
ATM fees		155		106
Overdraft fees		224		323
Safe deposit box rental		26		22
Loan related service fees		282		228
Debit card fees		443		370
Fiduciary activities		205		167
Commissions on mutual funds and annuities		26		30
Other income		152		143
Noninterest Income (in-scope of Topic 606)		1,606		1,461
Out-of-scope of Topic 606:
Net realized gains on sales of securities		33		169
Loan servicing fees		52		15
Gains on sales of loans		164		15
Earnings on and proceeds from bank-owned life insurance		217		222
Noninterest Income (out-of-scope of Topic 606)		466		421
Total Noninterest Income	$	2,072	$	1,882



	Nine months ended
	September 30,
(dollars in thousands)
Noninterest Income	2020		2019
In-scope of Topic 606:
Service charges on deposit accounts	$	278	$	205
ATM fees		354		287
Overdraft fees		715		1,017
Safe deposit box rental		79		71
Loan related service fees		464		451
Debit card fees		1,154		1,067
Fiduciary activities		533		454
Commissions on mutual funds and annuities		89		111
Other income		391		379
Noninterest Income (in-scope of Topic 606)		4,057		4,042
Out-of-scope of Topic 606:
Net realized gains on sales of securities		71		233
Loan servicing fees		68		53
Gains on sales of loans		285		125
Earnings on and proceeds from bank-owned life insurance		638		630
Noninterest Income (out-of-scope of Topic 606)		1,062		1,041
Total Noninterest Income	$	5,119	$	5,083

3. Earnings Per Share

Basic earnings per share represents income available to common stockholders divided by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflect additional common shares that would have been outstanding if dilutive potential common shares had been issued, as well as any adjustment to income that would result from the assumed issuance. Potential common shares that may be issued by the Company relate solely to outstanding stock options and restricted stock, and are determined using the treasury stock method.

The following table sets forth the weighted average shares outstanding used in the computations of basic and diluted earnings per share.



(in thousands)	Three Months Ended		Nine Months Ended
	September 30,		September 30,
	2020	2019	2020	2019
Weighted average shares outstanding	8,073	6,296	6,915	6,293
Less: Unvested restricted shares	(36)	(35)	(36)	(35)
Basic EPS weighted average shares outstanding	8,037	6,261	6,879	6,258
Basic EPS weighted average shares outstanding	8,037	6,261	6,879	6,258
Add: Dilutive effect of stock options and restricted shares	22	48	22	50
Diluted EPS weighted average shares outstanding	8,059	6,309	6,901	6,308

For the three and nine month periods ended September 30, 2020, there were 112,600 stock options that were anti-dilutive and thereby excluded from the earnings per share calculations based upon the closing price of the Company’s common stock of $24.32 per share as of September 30, 2020.

For the three and nine month periods ending September 30, 2019, there were 60,650 stock options that were anti-dilutive and thereby excluded from the earnings per share calculations based upon the closing price of the Company’s common stock of $31.61 per share on September 30, 2019.

4. Stock-Based Compensation

No awards were granted during the nine-month period ended September 30, 2020. As of September 30, 2020, there was $51,000 of total unrecognized compensation cost related to non-vested options granted in 2019 under the 2014 Equity Incentive Plan, which will be fully amortized by December 31, 2020. Compensation costs related to stock options amounted to $153,000 and $156,000 during the nine-month periods ended September 30, 2020 and 2019, respectively.

A summary of the Company’s stock option activity for the nine-month period ended September 30, 2020 is as follows:



		Weighted
		Average Exercise		Weighted Average		Aggregate
		Price		Remaining		Intrinsic Value
	Options	Per Share		Contractual Term		($000)
Outstanding at January 1, 2020	199,825	$	24.78	5.9	Yrs.	$	2,823
Granted	—		—	—			—
Exercised	(4,681)		17.87	2.6	Yrs.		—
Forfeited	—		—				—
Outstanding at September 30, 2020	195,144	$	24.94	5.2	Yrs.	$	654
Exercisable at September 30, 2020	168,394	$	23.18	4.6	Yrs.	$	654

Intrinsic value represents the amount by which the market price of the stock on the measurement date exceeded the exercise price of the option. The market price was $24.32 per share as of September 30, 2020 and $38.90 per share as of December 31, 2019.

A summary of the Company’s restricted stock activity for the nine-month periods ended September 30, 2020 and 2019 is as follows:



	2020			2019
		Weighted-Average				Weighted-Average
	Number of	Grant Date		Number of	Grant Date
	Restricted Stock	Fair Value		Restricted Stock	Fair Value
Non-vested, January 1,	36,195	$	31.65	34,615	$	27.82
Granted	—		—	—		—
Vested	—		—	—		—
Forfeited	—		—	—		—
Non-vested, September 30,	36,195	$	31.65	34,615	$	27.82

The expected future compensation expense relating to the 36,195 shares of non-vested restricted stock outstanding as of September 30, 2020 is $895,000. This cost will be recognized over the remaining vesting period of 4.25 years. Compensation costs related to restricted stock amounted to $250,000 and $217,000 during the nine-month periods ended September 30, 2020 and 2019, respectively.

5. Accumulated Other Comprehensive Income (Loss)

The following table presents the changes in accumulated other comprehensive income (loss) (in thousands) by component net of tax for the three and nine months ended September 30, 2020 and 2019:



	Unrealized gains (losses) on
	available for sale
	securities (a)
Balance as of June 30, 2020	$	4,782
Other comprehensive loss before reclassification		(91)
Amount reclassified from accumulated other comprehensive loss		(26)
Total other comprehensive loss		(117)
Balance as of September 30, 2020	$	4,665



	Unrealized gains (losses) on
	available for sale
	securities (a)
Balance as of June 30, 2019	$	440
Other comprehensive income before reclassification		835
Amount reclassified from accumulated other comprehensive income		(132)
Total other comprehensive income		703
Balance as of September 30, 2019	$	1,143




	Unrealized gains (losses) on
	available for sale
	securities (a)
Balance as of December 31, 2019	$	1,187
Other comprehensive income before reclassification		3,534
Amount reclassified from accumulated other comprehensive income		(56)
Total other comprehensive income		3,478
Balance as of September 30, 2020	$	4,665


	Unrealized gains (losses) on
	available for sale
	securities (a)
Balance as of December 31, 2018	$	(5,020)
Other comprehensive income before reclassification		6,346
Amount reclassified from accumulated other comprehensive income		(183)
Total other comprehensive income		6,163
Balance as of September 30, 2019	$	1,143

(a)All amounts are net of tax. Amounts in parentheses indicate debits.

The following table presents significant amounts reclassified out of each component of accumulated other comprehensive income (loss) (in thousands) for the three and nine months ended September 30, 2020 and 2019:



	Amount Reclassified
	From Accumulated				Affected Line Item in
	Other				Consolidated
	Comprehensive				Statements
Details about other comprehensive income	Income (Loss) (a)				of Income
	Three months ended
	September 30,
	2020		2019
Unrealized gains on available for sale securities	$	33	$	169	Net realized gains on sales of securities
		(7)		(37)	Income tax expense
	$	26	$	132

	Nine months ended
	September 30,
	2020		2019
Unrealized gains on available for sale securities	$	71	$	233	Net realized gains on sales of securities
		(15)		(50)	Income tax expense
	$	56	$	183

(a) Amounts in parentheses indicate debits to net income

6. Off-Balance Sheet Financial Instruments and Guarantees

The Bank is a party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and letters of credit. Those instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the balance sheets.

The Bank’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and letters of credit is represented by the contractual amount of those instruments. The Bank uses the same credit policies in making commitments and conditional obligations as it does for on-balance sheet instruments.

A summary of the Bank’s financial instrument commitments is as follows:



(in thousands)	September 30,
	2020		2019
Commitments to grant loans	$	76,029	$	49,806
Unfunded commitments under lines of credit		122,050		65,854
Standby letters of credit		5,654		3,687
	$	203,733	$	119,347

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since some of the commitments are expected to expire without being drawn upon, the total commitment amount does not necessarily represent future cash requirements. The Bank evaluates each customer’s credit worthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Bank upon extension of credit, is based on management’s credit evaluation of the customer and generally consists of real estate.

The Bank does not issue any guarantees that would require liability recognition or disclosure, other than its standby letters of credit. Standby letters of credit written are conditional commitments issued by the Bank to guarantee the performance of a customer to a third party. Generally, all letters of credit, when issued, have expiration dates within one year. The credit risk involved in issuing letters of credit is essentially the same as those that are involved in extending loan facilities to customers. The Bank, generally, holds

collateral and/or personal guarantees supporting these commitments. Management believes that the proceeds obtained through a liquidation of collateral and the enforcement of guarantees would be sufficient to cover the potential amount of future payments required under the corresponding guarantees. The current amount of the liability as of September 30, 2020 for guarantees under standby letters of credit issued is not material.

7. Securities

The amortized cost, gross unrealized gains and losses, and fair value of securities available for sale were as follows:



	September 30, 2020
			Gross		Gross
	Amortized		Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In Thousands)
Available for Sale:
States and political subdivisions	$	51,134	$	1,931	$	—	$	53,065
Corporate obligations		3,038		25		—		3,063
Mortgage-backed securities-
government sponsored entities		138,414		2,941		(47)		141,308
Total debt securities	$	192,586	$	4,897	$	(47)	$	197,436



	December 31, 2019
			Gross		Gross
	Amortized		Unrealized		Unrealized		Fair
	Cost		Gains		Losses		Value
	(In Thousands)
Available for Sale:
States and political subdivisions	$	70,015	$	1,293	$	(3)	$	71,305
Corporate obligations		4,097		3		-		4,100
Mortgage-backed securities-government
sponsored entities		135,646		238		(1,084)		134,800
Total debt securities	$	209,758	$	1,534	$	(1,087)	$	210,205

The following tables show the Company’s investments’ gross unrealized losses and fair value aggregated by length of time that individual securities have been in a continuous unrealized loss position (in thousands):




	September 30, 2020
	Less than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
Mortgage-backed securities-government sponsored entities	$	20,888	$	(47)	$	—	$	—	$	20,888	$	(47)
	$	20,888	$	(47)	$	—	$	—	$	20,888	$	(47)



	December 31, 2019
	Less than 12 Months				12 Months or More				Total
	Fair Value		Unrealized Losses		Fair Value		Unrealized Losses		Fair Value		Unrealized Losses
States and political subdivisions	$	1,296	$	(2)	$	481	$	(1)	$	1,777	$	(3)
Mortgage-backed securities-government sponsored entities		32,415		(241)		61,096		(843)		93,511		(1,084)
	$	33,711	$	(243)	$	61,577	$	(844)	$	95,288	$	(1,087)

At September 30, 2020, the Company had eight debt securities in an unrealized loss position in the less than twelve months category and no debt securities in the twelve months or more category. In Management’s opinion the unrealized losses reflect changes in interest rates subsequent to the acquisition of specific securities. No other-than-temporary-impairment charges were recorded in

2020. Management believes that all unrealized losses represent temporary impairment of the securities as the Company does not have the intent to sell the securities and it is more likely than not that it will not have to sell the securities before recovery of its cost basis.

The amortized cost and fair value of debt securities as of September 30, 2020 by contractual maturity are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to prepay obligations with or without call or prepayment penalties.


	Available for Sale
	Amortized Cost		Fair Value
		(In Thousands)
Due in one year or less	$	4,348	$	4,386
Due after one year through five years		7,385		7,447
Due after five years through ten years		17,958		18,415
Due after ten years		24,481		25,880
		54,172		56,128
Mortgage-backed securities-government sponsored entities		138,414		141,308
	$	192,586	$	197,436

Gross realized gains and gross realized losses on sales of securities available for sale were as follows (in thousands):



	Three Months				Nine Months
	Ended September 30,				Ended September 30,
	2020		2019		2020		2019
Gross realized gains	$	33	$	169	$	71	$	233
Gross realized losses		—		—		—		—
Net realized gain	$	33	$	169	$	71	$	233
Proceeds from sales of securities	$	2,425	$	19,326	$	24,497	$	22,862

Securities with a carrying value of $189,346,000 and $157,233,000 at September 30, 2020 and December 31, 2019, respectively, were pledged to secure public deposits, securities sold under agreements to repurchase and for other purposes as required or permitted by law.

8. Loans Receivable and Allowance for Loan Losses

Set forth below is selected data relating to the composition of the loan portfolio at the dates indicated (dollars in thousands):



	September 30, 2020				December 31, 2019
Real Estate Loans:
Residential	$	263,404	18.6	%	$	229,781	24.9	%
Commercial		574,123	40.5			391,327	42.3
Agricultural		68,340	4.8			—	—
Construction		20,797	1.5			17,732	1.9
Commercial loans		285,295	20.1			134,150	14.5
Other agricultural loans		42,297	3.0			—	—
Consumer loans to individuals		162,217	11.5			151,686	16.4
Total loans		1,416,473	100.0	%		924,676	100.0	%
Deferred fees, net		(1,811)				(95)
Total loans receivable		1,414,662				924,581
Allowance for loan losses		(11,674)				(8,509)
Net loans receivable	$	1,402,988			$	916,072

During 2020 the Company participated in the Paycheck Protection Program (“PPP”), administered directly by the United States Small Business Administration (“SBA”). The PPP provides loans to small businesses who were affected by economic conditions as a result of COVID-19 to provide cash-flow assistance to employers who maintain their payroll (including healthcare and certain related expenses), mortgage interest, rent, leases, utilities and interest on existing debt during the COVID-19 emergency. As of September 30, 2020, the Company had outstanding principal balances of $95,035,000 in PPP loans. The PPP loans are fully guaranteed by the SBA and may be eligible for forgiveness by the SBA to the extent that the proceeds are used to cover eligible payroll costs, interest costs,

rent, and utility costs over a period of up to 24 weeks after the loan is made as long as certain conditions are met regarding employee retention and compensation levels. PPP loans deemed eligible for forgiveness by the SBA will be repaid by the SBA to the Company. PPP loans are included in the Commercial loan category.

In accordance with the SBA terms and conditions on these PPP loans, the Company received approximately $2.5 million in fees associated with the processing of these loans. Upon funding of the loan, these fees were deferred and will be amortized over the life of the loan as an adjustment to yield in accordance with FASB ASC 310-20-25-2.

The following table presents information regarding loans acquired and accounted for in accordance with ASC 310-30 (in thousands):



	September 30, 2020		December 31, 2019
Outstanding Balance	$	15,344	$	793
Carrying Amount	$	8,586	$	696

As a result of the acquisition of UpState New York Bancorp, Inc. (“UpState”), the Company added $15,410,000 of loans that were accounted for in accordance with ASC 310-30. Based on a review of the loans acquired by the Company’s senior lending management, which included an analysis of credit deterioration of the loans since origination, the Company recorded a specific credit fair value adjustment of $6,937,000. For loans that were acquired with specific evidence of deterioration in credit quality, loan losses will be accounted for through a reduction of the specific reserve and will not impact the allowance for loan losses until actual losses exceed the allotted reserves. For loans acquired without a deterioration of credit quality, losses incurred will result in adjustments to the allowance for loan losses through the allowance for loan loss adequacy calculation.

Changes in the accretable yield for purchased credit impaired loans for the nine-months ended September 30, 2019 and 2020, were as follows:



	2020		2019
Balance at beginning of period	$	97	$	168
Additions		1,724		—
Accretion		(179)		(29)
Reclassification and other		(96)		—
Balance at end of period	$	1,546	$	139

Loans acquired with credit deterioration of $15,410,000 and accounted for in accordance with ASC 310-30 were individually evaluated to estimate credit losses and a net recovery amount for each loan. The net cash flows for each loan were then discounted to present value using a risk-adjusted market rate. The table below presents the components of the purchase accounting adjustments:



(In Thousands)	July 7, 2020
Contractually required principal and interest	$	15,410
Non-accretable discount		(5,213)
Expected cash flows		10,197
Accretable discount		(1,724)
Estimated fair value	$	8,473

The Company maintains a loan review system, which allows for a periodic review of our loan portfolio and the early identification of potential impaired loans. Such system takes into consideration, among other things, delinquency status, size of loans, type and market value of collateral and financial condition of the borrowers. Specific loan loss allowances are established for identified losses based on a review of such information. A loan evaluated for impairment is considered to be impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due according to the contractual terms of the loan agreement. All loans identified as impaired are evaluated independently. We do not aggregate such loans for evaluation purposes. Impairment is measured on a loan-by-loan basis for commercial and construction loans by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price, or the fair value of the collateral if the loan is collateral-dependent.

Large groups of smaller balance homogeneous loans are collectively evaluated for impairment. Accordingly, the Company does not separately identify individual consumer and residential mortgage loans for impairment disclosures, unless such loans are part of a larger relationship that is impaired, or are classified as a troubled debt restructuring.

Foreclosed assets acquired in settlement of loans are carried at fair value less estimated costs to sell and are included in foreclosed real estate owned on the Consolidated Balance Sheets. As of September 30, 2020 and December 31, 2019, foreclosed real estate owned totaled $965,000 and $1,556,000, respectively. During the nine months ended September 30, 2020, there were no additions to the foreclosed real estate category. The Company disposed of one property that was previously transferred to foreclosed real estate owned with a carrying value of $591,000 through the sale of the property. As of September 30, 2020, the Company has initiated formal foreclosure proceedings on three properties classified as consumer residential mortgages with an aggregate carrying value of $440,000.

The following table shows the amount of loans in each category that were individually and collectively evaluated for impairment at the dates indicated:



	Real Estate Loans
									Commercial			Other	Consumer
	Residential		Commercial			Agricultural	Construction		Loans			Agricultural	Loans		Total
September 30, 2020	(In thousands)
Individually evaluated for impairment	$	—	$	1,654	$	—	$	—	$	—	$	—	$	—	$	1,654
Loans acquired with deteriorated credit quality		122		3,771		2,078		190		245		2,180		—		8,586
Collectively evaluated for impairment		263,282		568,698		66,262		20,607		285,050		40,117		162,217		1,406,233
Total Loans	$	263,404	$	574,123	$	68,340	$	20,797	$	285,295	$	42,297	$	162,217	$	1,416,473



	Real Estate Loans
							Commercial		Consumer
	Residential		Commercial		Construction		Loans		Loans		Total
December 31, 2019	(In thousands)

Individually evaluated for impairment	$	-	$	2,144	$	-	$	-	$	-	$	2,144
Loans acquired with deteriorated credit quality		476		220		-		-		-		696
Collectively evaluated for impairment		229,305		388,963		17,732		134,150		151,686		921,836
Total Loans	$	229,781	$	391,327	$	17,732	$	134,150	$	151,686	$	924,676

The following table includes the recorded investment and unpaid principal balances for impaired loans with the associated allowance amount, if applicable.



			Unpaid
	Recorded		Principal		Associated
	Investment		Balance		Allowance
September 30, 2020				(in thousands)
With no related allowance recorded:
Real Estate Loans:
Commercial	$	1,654	$	2,287		—
Total Impaired Loans	$	1,654	$	2,287		—



			Unpaid
	Recorded		Principal		Associated
	Investment		Balance		Allowance
December 31, 2019				(in thousands)
With no related allowance recorded:
Real Estate Loans:
Commercial	$	143	$	394	$	—
Subtotal		143		394		—
With an allowance recorded:
Real Estate Loans
Commercial		2,001		2,001		417
Subtotal		2,001		2,001		417
Total:
Real Estate Loans:
Commercial		2,144		2,395		417
Total Impaired Loans	$	2,144	$	2,395	$	417

The following table presents the average recorded investment in impaired loans and the related amount of interest income recognized during the three-month periods ended September 30, 2020 and 2019, respectively (in thousands):



	Average Recorded				Interest Income
	Investment				Recognized
	2020		2019		2020		2019
Real Estate Loans:
Commercial		1,874		633		2		—
Total	$	1,874	$	633	$	2	$	—

The following table presents the average recorded investment in impaired loans and the related amount of interest income recognized during the nine-month periods ended September 30, 2020 and 2019, respectively (in thousands):




	Average Recorded				Interest Income
	Investment				Recognized
	2020		2019		2020		2019
Real Estate Loans:
Commercial		1,986		759		8		24
Total	$	1,986	$	759	$	8	$	24

Troubled debt restructured loans are those loans whose terms have been renegotiated to provide a reduction or deferral of principal or interest as a result of financial difficulties experienced by the borrower, who could not obtain comparable terms from alternate financing sources. As of September 30, 2020 and December 31, 2019, troubled debt restructured loans totaled $91,000 and $99,000, respectively, with no specific reserve. For the nine-month period ended September 30, 2020 and 2019, there were no new loans identified as troubled debt restructurings. During 2019, the Company recognized a charge-off $451,000 on a loan that was previously identified as a troubled debt restructuring. The loan was transferred to foreclosed real estate during the first quarter of 2019 with a carrying value of $608,000.

On April 7, 2020, federal banking regulators issued a revised interagency statement that included guidance on their approach for the accounting of loan modifications in light of the economic impact of the COVID-19 pandemic. The guidance interprets current accounting standards and indicates that a lender can conclude that a borrower is not experiencing financial difficulty if short-term modifications are made in response to COVID-19, such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant related to the loans in which the borrower is less than 30 days past due on its contractual payments at the time a modification program is implemented. The agencies confirmed in working with the staff of the FASB that short-term modifications made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs.

Management uses an eight point internal risk rating system to monitor the credit quality of the overall loan portfolio. The first four categories are considered not criticized, and are aggregated as “Pass” rated. The criticized rating categories utilized by management generally follow bank regulatory definitions. The Special Mention category includes assets that are currently protected but are potentially weak, resulting in an undue and unwarranted credit risk, but not to the point of justifying a Substandard classification. Loans in the Substandard category have well-defined weaknesses that jeopardize the liquidation of the debt, and have a distinct possibility that some loss will be sustained if the weaknesses are not corrected. All loans greater than 90 days past due are considered Substandard. Any portion of a loan that has been charged off is placed in the Loss category.

To help ensure that risk ratings are accurate and reflect the present and future capacity of borrowers to repay a loan as agreed, the Bank has a structured loan rating process with several layers of internal and external oversight. Generally, consumer and residential mortgage loans are included in the Pass categories unless a specific action, such as nonperformance, repossession, or death occurs to raise awareness of a possible credit event. The Company’s Loan Review Department is responsible for the timely and accurate risk rating of the loans on an ongoing basis. Every credit which must be approved by Loan Committee or the Board of Directors is assigned a risk rating at time of consideration. Loan Review also annually reviews relationships of $1,500,000 and over to assign or re-affirm risk ratings. Loans in the Substandard categories that are collectively evaluated for impairment are given separate consideration in the determination of the allowance.

The following table presents the classes of the loan portfolio summarized by the aggregate Pass and the criticized categories of Special Mention, Substandard, Doubtful and Loss within the internal risk rating system as of September 30, 2020 and December 31, 2019 (in thousands):



			Special				Doubtful
	Pass		Mention		Substandard		or Loss		Total
September 30, 2020
Commercial real estate loans	$	558,137	$	10,341	$	5,645	$	—	$	574,123
Agricultural real estate loans		—		5,554		3,529		—		68,340
Commercial loans		284,625		275		395		—		285,295
Other agricultural loans		—		2,595		2,270		—		42,297
Total	$	842,762	$	18,765	$	11,839	$	—	$	970,055



			Special				Doubtful
	Pass		Mention		Substandard		or Loss		Total
December 31, 2019
Commercial real estate loans	$	376,109	$	12,268	$	2,950	$	—	$	391,327
Commercial loans		133,695		248		207		—		134,150
Total	$	509,804	$	12,516	$	3,157	$	—	$	525,477

For residential real estate loans, construction loans and consumer loans, the Company evaluates credit quality based on the performance of the individual credits. The following table presents the recorded investment in the loan classes based on payment activity as of September 30, 2020 and December 31, 2019 (in thousands):



	Performing		Nonperforming		Total
September 30, 2020
Residential real estate loans	$	262,741	$	663	$	263,404
Construction		20,797		—		20,797
Consumer loans		162,078		139		162,217
Total	$	445,616	$	802	$	446,418



	Performing		Nonperforming		Total
December 31, 2019
Residential real estate loans	$	229,214	$	567	$	229,781
Construction		17,732		—		17,732
Consumer loans		151,607		79		151,686
Total	$	398,553	$	646	$	399,199

Management further monitors the performance and credit quality of the loan portfolio by analyzing the age of the portfolio as determined by the length of time a recorded payment is past due. The following table presents the classes of the loan portfolio summarized by the aging categories of performing loans and nonaccrual loans as of September 30, 2020 and December 31, 2019 (in thousands):



	Current		31-60 Days Past Due		61-90 Days Past Due		Greater than 90 Days Past Due and still accruing		Nonaccrual		Total Past Due and Non-Accrual		Purchased Credit-Impaired		Total Loans
September 30, 2020
Real Estate loans
Residential	$	261,906	$	443	$	270	$	-	$	663	$	1,376	$	122	$	263,404
Commercial		568,601		420		51		-		1,280		1,751		3,771		574,123
Agricultural		65,557		29						676		705		2,078		68,340
Construction		20,607		-		-		-		-		-		190		20,797
Commercial loans		283,130		878		19		1,000		23		1,920		245		285,295
Other agricultural loans		39,844		10						263		273		2,180		42,297
Consumer loans		161,682		346		50		-		139		535		-		162,217
Total	$	1,401,327	$	2,126	$	390	$	1,000	$	3,044	$	6,560	$	8,586	$	1,416,473



	Current		31-60 Days Past Due		61-90 Days Past Due		Greater than 90 Days Past Due and still accruing		Nonaccrual		Total Past Due and Non-Accrual			Purchased Credit-Impaired		Total Loans
December 31, 2019
Real Estate loans
Residential	$	227,766	$	727	$	245	$	-	$	567	$	1,539	-	$	476	$	229,781
Commercial		387,897		176		2,935		-		99		3,210	-		220		391,327
Construction		17,695		-		37		-		-		37	-		-		17,732
Commercial loans		134,018		82		-		-		50		132	-		-		134,150
Consumer loans		151,309		233		65		-		79		377	-		-		151,686
Total	$	918,685	$	1,218	$	3,282	$	-	$	795	$	5,295	-	$	696	$	924,676

Management reviews the loan portfolio on a quarterly basis using a defined, consistently applied process in order to make appropriate and timely adjustments to the allowance for loan losses. When information confirms all or part of specific loans to be uncollectible, these amounts are promptly charged off against the allowance.

As of September 30, 2020, the allocation of the allowance pertaining to each major category of loans is higher than the allocation as of December 31, 2019. This increase is due primarily to an increase in the qualitative factor for economic conditions which worsened as a result of the COVID-19 pandemic. The increase in the economic factor added $2.2 million to the required allowance for loan losses. As of September 30, 2020, the Company has also added qualitative factors related to the pandemic to capture some of the risk associated with higher-risk industries and to recognize risk related to loans that have been granted deferral of payments due to COVID-19. At September 30, 2020, the allowance for loan losses includes $1.5 million of COVID related factors. These increases in the required allowance were offset partially by a decrease in the qualitative factor relating to loan growth which decreased by $986,000 due to a reduction in loan growth from 8.75% in 2019 to projected growth of approximately 2.00% for the year

of 2020. The 2020 growth excludes growth in Paycheck Protection Program loans which are fully guaranteed by the Small Business Association as well as loans acquired from UpState.

The following table presents the allowance for loan losses by the classes of the loan portfolio:


(In thousands)	Residential Real Estate		Commercial Real Estate		Construction		Commercial		Consumer		Total
Beginning balance, December 31, 2019	$	1,552	$	4,687	$	95	$	949	$	1,226	$	8,509
Charge Offs		(41)		(433)		—		(18)		(275)		(767)
Recoveries		5		10		—		36		31		82
Provision for loan losses		162		2,904		30		242		512		3,850
Ending balance, September 30, 2020	$	1,678	$	7,168	$	125	$	1,209	$	1,494	$	11,674
Ending balance individually evaluated ‎for impairment	$	—	$	—	$	—	$	—	$	—	$	—
Ending balance collectively evaluated ‎for impairment	$	1,678	$	7,168	$	125	$	1,209	$	1,494	$	11,674


(In thousands)	Residential Real Estate		Commercial Real Estate		Construction		Commercial		Consumer		Total
Beginning balance, June 30, 2020	$	1,652	$	6,079	$	86	$	1,076	$	1,419	$	10,312
Charge Offs		(40)		(400)		-		-		(83)		(523)
Recoveries		2		4		-		18		11		35
Provision for loan losses		64		1,485		39		115		147		1,850
Ending balance, September 30, 2020	$	1,678	$	7,168	$	125	$	1,209	$	1,494	$	11,674



(In thousands)	Residential Real Estate		Commercial Real Estate		Construction		Commercial		Consumer		Total
Beginning balance, December 31, 2018	$	1,328	$	5,455	$	93	$	712	$	864	$	8,452
Charge Offs		(90)		(615)		—		(254)		(246)		(1,205)
Recoveries		20		18		—		31		39		108
Provision for loan losses		310		(292)		14		454		564		1,050
Ending balance, September 30, 2019	$	1,568	$	4,566	$	107	$	943	$	1,221	$	8,405
Ending balance individually evaluated ‎for impairment	$	—	$	—	$	—	$	—	$	—	$	—
Ending balance collectively evaluated ‎for impairment	$	1,568	$	4,566	$	107	$	943	$	1,221	$	8,405


(In thousands)	Residential Real Estate		Commercial Real Estate		Construction		Commercial		Consumer		Total
Beginning balance, June 30, 2019	$	1,447	$	4,694	$	112	$	896	$	1,079	$	8,228
Charge Offs		(15)		—		—		(20)		(111)		(146)
Recoveries		5		4		—		10		4		23
Provision for loan losses		131		(132)		(5)		57		249		300
Ending balance, September 30, 2019	$	1,568	$	4,566	$	107	$	943	$	1,221	$	8,405

The Company’s primary business activity as of September 30, 2020 was with customers located in northeastern Pennsylvania and the New York counties of Delaware, Sullivan, Ontario, Otsego and Yates. Accordingly, the Company has extended credit primarily to commercial entities and individuals in this area whose ability to honor their contracts is influenced by the region’s economy.

As of September 30, 2020, the Company considered its concentration of credit risk to be acceptable. The highest concentrations are in commercial rentals with $119.7 million of loans outstanding, or 8.5% of total loans outstanding, and residential rentals with loans outstanding of $117.2 million, or 8.3% of loans outstanding. During 2020, the Company did not recognize any charge offs on loans in the named concentrations.

9. Operating Leases

The Company leases eight office locations under operating leases. Several assumptions and judgments were made when applying the requirements of Topic 842 to the Company’s existing lease commitments, including the allocation of consideration in the contracts between lease and nonlease components, determination of the lease term, and determination of the discount rate used in calculating the present value of the lease payments.

The Company has elected to account for the variable nonlease components, such as common area maintenance charges, utilities, real estate taxes, and insurance, separately from the lease component. Such variable nonlease components are reported in net occupancy expense on the Consolidated Statements of Income when paid. These variable nonlease components were excluded from the calculation of the present value of the remaining lease payments, therefore, they are not included in other assets and other liabilities on the Consolidated Balance Sheets. The lease cost associated with the operating leases for the nine-month periods ending September 30, 2020 and 2019, amounted to $425,000 and $382,000 respectively.

Certain of the Company’s leases contain options to renew the lease after the initial term. Management considers the Company’s historical pattern of exercising renewal options on leases and the positive performance of the leased locations, when determining whether it is reasonably certain that the leases will be renewed. If management concludes that there is reasonable certainty about the renewal option, it is included in the calculation of the remaining term of each applicable lease. The discount rate utilized in calculating the present value of the remaining lease payments for each lease was the Federal Home Loan Bank of Pittsburgh advance rate corresponding to the remaining maturity of the lease. The following table presents the weighted-average remaining lease term and discount rate for the leases outstanding at September 30, 2020.


	Operating
Weighted-average remaining term		12.4
Weighted-average discount rate		3.20%

The following table presents the undiscounted cash flows due related to operating leases as of September 30, 2020, along with a reconciliation to the discounted amount recorded on the Consolidated Balance Sheets:


Undiscounted cash flows due (in thousands)		Operating

2020	$	140
2021		561
2022		546
2023		534
2024		544
2025 and thereafter		3,880
Total undiscounted cash flows		6,205
Discount on cash flows		(1,121)
Total lease liabilities	$	5,084

10. Fair Value of Assets and Liabilities

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. In accordance with fair value accounting guidance, the Company measures, records, and reports various types of assets and liabilities at fair value on either a recurring or non-recurring basis in the Consolidated Financial Statements. Those assets and liabilities are presented in the sections entitled “Assets and Liabilities Required to be Measured and Reported at Fair Value on a Recurring Basis” and “Assets and Liabilities Required to be Measured and Reported at Fair Value on a Non-Recurring Basis”. There are three levels of inputs that may be used to measure fair values:

Level 1 – Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.

Level 2 – Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.

Level 3 – Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability.

The methods of determining the fair value of assets and liabilities presented in this note are consistent with our methodologies disclosed in Note 15 of the Company’s 2019 Form 10-K.

Assets and Liabilities Required to be Measured and Reported at Fair Value on a Recurring Basis

For financial assets measured at fair value on a recurring basis, the fair value measurements by level within the fair value hierarchy used at September 30, 2020 and December 31, 2019 are as follows:



	Fair Value Measurement Using
	Reporting Date
Description	Total		Level 1		Level 2		Level 3
	(In thousands)
September 30, 2020
Available for Sale:
States and political subdivisions	$	53,065	$	-	$	53,065	$	-
Corporate obligations		3,063		-		3,063		-
Mortgage-backed securities-government
sponsored entities		141,308		-		141,308		-
Total	$	197,436	$	-	$	197,436	$	-


Description	Total		Level 1		Level 2		Level 3
	(In thousands)
December 31, 2019
Available for Sale:
States and political subdivisions	$	71,305	$	-	$	71,305	$	-
Corporate obligations		4,100		-		4,100		-
Mortgage-backed securities-government
sponsored entities		134,800		-		134,800		-
Total	$	210,205	$	-	$	210,205	$	-

Securities:

The fair value of securities available for sale (carried at fair value) and held to maturity (carried at amortized cost) are determined by obtaining quoted market prices on nationally recognized securities exchanges (Level 1), or matrix pricing (Level 2), which is a mathematical technique used widely in the industry to value debt securities without relying exclusively on quoted market prices for the specific securities but rather by relying on the securities’ relationship to other benchmark quoted prices. For certain securities which are not traded in active markets or are subject to transfer restrictions, valuations are adjusted to reflect illiquidity and/or non-transferability, and such adjustments are generally based on available market evidence (Level 3). In the absence of such evidence, management’s best estimate is used. Management’s best estimate consists of both internal and external support on certain Level 3 investments. Internal cash flow models using a present value formula that includes assumptions market participants would use along with indicative exit pricing obtained from broker/dealers (where available) are used to support fair values of certain Level 3 investments, if applicable.

Assets and Liabilities Required to be Measured and Reported at Fair Value on a Non-Recurring Basis

For financial assets measured at fair value on a nonrecurring basis, the fair value measurements by level within the fair value hierarchy used at September 30, 2020 and December 31, 2019 are as follows:



			Fair Value Measurement Using Reporting Date

(In thousands)

Description	Total		Level 1		Level 2		Level 3
September 30, 2020
Impaired Loans	$	-	$	-	$	-	$	-
Foreclosed Real Estate Owned		965		-		-		965
December 31, 2019
Impaired Loans	$	1,584	$	-	$	-	$	1,584
Foreclosed Real Estate Owned		1,556		-		-		1,556

Impaired loans (generally carried at fair value):

The Company measures impairment generally based on the fair value of the loan’s collateral. Fair value is generally determined based upon independent third-party appraisals of the properties, or discounted cash flows based upon the lowest level of input that is significant to the fair value measurements.

As of September 30, 2020, the fair value investment in impaired loans was $0 since no loans required a specific reserve at period end.

As of December 31, 2019, the fair value investment in impaired loans totaled $1,584,000 which included two loans that required a valuation allowance of $417,000 since the estimated realizable value of the collateral or the discounted cash flows were not sufficient to cover the recorded investment in the loans. As of December 31, 2019, the Company had not recognized any charge-offs against the allowance for loan losses on these impaired loans.

Foreclosed real estate owned (carried at fair value):

Real estate properties acquired through loan foreclosures, or by deed in lieu of loan foreclosure are to be sold and are carried at fair value less estimated cost to sell. Fair value is based upon independent market prices, appraised value of the collateral or management’s estimation of the value of the collateral. These assets are included in Level 3 fair value based upon the lowest level of input that is significant to the fair value measurement.

The following table presents additional quantitative information about assets measured at fair value on a non-recurring basis and for which the Company has utilized Level 3 inputs to determine fair value:



	Quantitative Information about Level 3 Fair Value Measurements
(dollars in thousands)	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range (Weighted Average)
September 30, 2020
Impaired loans	$	-	Appraisal of collateral(1)	Appraisal adjustments(2)	-
Foreclosed real estate owned	$	965	Appraisal of collateral(1)	Liquidation Expenses(2)	7.00% (7.00%)



	Quantitative Information about Level 3 Fair Value Measurements
(dollars in thousands)	Fair Value Estimate		Valuation Techniques	Unobservable Input	Range (Weighted Average)
December 31, 2019
Impaired loans	$	1,531	Appraisal of collateral(1)	Appraisal adjustments(2)	10.00% (10.00%)
Impaired loans	$	53	Present value of future cash flows	Loan discount rate	4.00-6.97% (5.55%)
				Probability of default	0%
Foreclosed real estate owned	$	1,556	Appraisal of collateral(1)	Liquidation Expenses(2)	0-7.00% (4.34%)

(1)Fair value is generally determined through independent appraisals of the underlying collateral, which generally include various Level 3 inputs which are not identifiable, less any associated allowance.

(2)Appraisals may be adjusted by management for qualitative factors such as economic conditions and estimated liquidation expenses. The range and weighted average of liquidation expenses and other appraisal adjustments are presented as a percent of the appraisal.

Assets and Liabilities Not Required to be Measured or Reported at Fair Value

The following information should not be interpreted as an estimate of the fair value of the entire Company since a fair value calculation is only provided for a limited portion of the Company’s assets and liabilities. Due to a wide range of valuation techniques and the degree of subjectivity used in making the estimates, comparisons between the Company’s disclosures and those of other companies may not be meaningful. The following methods and assumptions were used to estimate the fair values of the Company’s financial instruments at September 30, 2020 and December 31, 2019.

Loans receivable (carried at cost):

The fair values of loans are estimated using discounted cash flow analyses, using market rates at the balance sheet date that reflect the credit and interest rate-risk inherent in the loans. Projected future cash flows are calculated based upon contractual maturity or call dates, projected repayments and prepayments of principal. Generally, for variable rate loans that reprice frequently and with no significant change in credit risk, fair values are based on carrying values.

Mortgage servicing rights (generally carried at cost)

The Company utilizes a third party provider to estimate the fair value of certain loan servicing rights. Fair value for the purpose of this measurement is defined as the amount at which the asset could be exchanged in a current transaction between willing parties, other than in a forced liquidation.

Deposit liabilities (carried at cost):

The fair values disclosed for demand deposits (e.g., interest and noninterest checking, passbook savings and money market accounts) are, by definition, equal to the amount payable on demand at the reporting date (i.e., their carrying amounts). Fair values for fixed-rate certificates of deposit are estimated using a discounted cash flow calculation that applies interest rates currently being offered in the market on certificates to a schedule of aggregated expected monthly maturities on time deposits.

Other borrowings (carried at cost):

Fair values of FHLB advances are estimated using discounted cash flow analysis, based on quoted prices for new FHLB advances with similar credit risk characteristics, terms and remaining maturity. These prices obtained from this active market represent a fair value that is deemed to represent the transfer price if the liability were assumed by a third party.

The estimated fair values of the Bank’s financial instruments not required to be measured or reported at fair value were as follows at September 30, 2020 and December 31, 2019. (In thousands)



	Fair Value Measurements at September 30, 2020
	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
Financial assets:
Cash and cash equivalents (1)	$	124,440	$	124,440	$	124,440	$	-	$	-
Loans receivable, net		1,402,988		1,494,158		-		-		1,494,158
Mortgage servicing rights		324		406		-		-		406
Regulatory stock (1)		3,876		3,876		3,876		-		-
Bank owned life insurance (1)		39,400		39,400		39,400		-		-
Accrued interest receivable (1)		6,104		6,104		6,104		-		-
Financial liabilities:
Deposits		1,515,922		1,521,857		980,745		-		541,112
Short-term borrowings (1)		69,294		69,294		69,294		-		-
Other borrowings		46,438		47,567		-		-		47,567
Accrued interest payable (1)		2,194		2,194		2,194		-		-
Off-balance sheet financial instruments:
Commitments to extend credit and ‎outstanding letters of credit		-		-		-		-		-



	Fair Value Measurements at December 31, 2019
	Carrying Amount		Fair Value		Level 1		Level 2		Level 3
Financial assets:
Cash and cash equivalents (1)	$	15,415	$	15,415	$	15,415	$	-	$	-
Loans receivable, net		916,072		943,143		-		-		943,143
Mortgage servicing rights		187		226		-		-		226
Regulatory stock (1)		4,844		4,844		4,844		-		-
Bank owned life insurance (1)		38,763		38,763		38,763		-		-
Accrued interest receivable (1)		3,719		3,719		3,719		-		-
Financial liabilities:
Deposits		957,529		961,120		596,811		-		364,309
Short-term borrowings (1)		62,256		62,256		62,256		-		-
Other borrowings		56,438		56,618		-		-		56,618
Accrued interest payable (1)		2,432		2,432		2,432		-		-
Off-balance sheet financial instruments:
Commitments to extend credit and ‎outstanding letters of credit		-		-		-		-		-

(1)This financial instrument is carried at cost, which approximates the fair value of the instrument.

11. New and Recently Adopted Accounting Pronouncements

New Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. This Update is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. The underlying premise of the Update is that financial assets measured at amortized cost should be presented at the net amount expected to be collected, through an allowance for credit losses that is deducted from the amortized cost basis. The allowance for credit losses should reflect management’s current estimate of credit losses that are expected to occur over the remaining life of a financial asset. The income statement will be affected for the measurement of credit losses for newly recognized financial assets, as well as the expected increases or decreases of expected credit losses that have taken place during the period. With certain exceptions, transition to the new requirements will be through a cumulative-effect adjustment to opening retained earnings as of the beginning of the first reporting period in which the guidance is adopted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). This Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. We expect to recognize a one-time cumulative-effect adjustment to the allowance for loan losses as of the beginning of the first reporting period in which the new standard is effective

but cannot yet determine the magnitude of any such one-time adjustment or the overall impact of the new guidance on the consolidated financial statements.

In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment. To simplify the subsequent measurement of goodwill, the FASB eliminated Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination. Instead, under the amendments in this Update, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842), which deferred the effective date for ASC 350, Intangibles – Goodwill and Other, for smaller reporting companies to fiscal years beginning after December 15, 2022, and interim periods within those fiscal years. This Update is not expected to have a significant impact on the Company’s financial statements.

In August 2018, the FASB issued ASU 2018-14, Compensation – Retirement Benefits (Topic 715-20). This Update amends ASC 715 to add, remove, and clarify disclosure requirements related to defined benefit pension and other postretirement plans. The Update eliminates the requirement to disclose the amounts in accumulated other comprehensive income expected to be recognized as part of net periodic benefit cost over the next year. The Update also removes the disclosure requirements for the effects of a one percentage point change on the assumed health care costs and the effect of this change in rates on service cost, interest cost, and the benefit obligation for postretirement health care benefits. This Update is effective for public business entities for fiscal years ending after December 15, 2020, and must be applied on a retrospective basis. For all other entities, this Update is effective for fiscal years ending after December 15, 2021. This Update is not expected to have a significant impact on the Company’s financial statements.

In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, Derivatives and Hedging (Topic 815), and Financial Instruments (Topic 825), which affects a variety of topics in the Codification and applies to all reporting entities within the scope of the affected accounting guidance. Topic 326, Financial Instruments – Credit Losses, amendments are effective for SEC registrants for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. For all other public business entities, the effective date is for fiscal years beginning after December 15, 2020, and for all other entities, the effective date is for fiscal years beginning after December 15, 2021. Topic 815, Derivatives and Hedging, amendments are effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods beginning after December 15, 2020. For entities that have adopted the amendments in Update 2017-12, the effective date is as of the beginning of the first annual period beginning after the issuance of this Update. Topic 825, Financial Instruments, amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). This Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Furthermore, the ASU provides a one-year deferral of the effective dates of the ASUs on derivatives and hedging for companies that are not public business entities. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.

In May 2019, the FASB issued ASU 2019-05, Financial Instruments – Credit Losses (Topic 326), which allows entities to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost upon adoption of the new credit losses standard. To be eligible for the transition election, the existing financial asset must otherwise be both within the scope of the new credit losses standard and eligible for applying the fair value option in ASC 825-10. The election must be applied on an instrument-by-instrument basis and is not available for either available-for-sale or held-to-maturity debt securities. For entities that elect the fair value option, the difference between the carrying amount and the fair value of the financial asset would be recognized through a cumulative-effect adjustment to opening retained earnings as of the date an entity adopted ASU 2016-13. Changes in fair value of that financial asset would subsequently be reported in current earnings. For entities that have not yet adopted ASU 2016-13, the effective dates and transition requirements are the same as those in ASU 2016-13. For entities that have adopted ASU 2016-13, ASU 2019-05 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is permitted once ASU 2016-13 has been adopted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The Update defers the effective date of ASU 2016-13 for SEC filers that are eligible to be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company qualifies as a smaller reporting company and does not expect to early adopt ASU 2016-13.

In November 2019, the FASB issued ASU 2019-10, Financial Instruments ‒ Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842). The Update defers the effective dates of ASU 2016-13 for SEC filers that are eligible to

be smaller reporting companies, non-SEC filers, and all other companies, to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. This Update also amends the mandatory effective date for the elimination of Step 2 from the goodwill impairment test under ASU No. 2017-04, Intangibles ‒ Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (Goodwill), to align with those used for credit losses. Furthermore, the ASU provides a one-year deferral of the effective dates of the ASUs on derivatives and hedging and leases for companies that are not public business entities. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.

In November 2019, the FASB issued ASU 2019-11, Codification Improvements to Topic 326, Financial Instruments – Credit Losses, to clarify its new credit impairment guidance in ASC 326, based on implementation issues raised by stakeholders. This Update clarified, among other things, that expected recoveries are to be included in the allowance for credit losses for these financial assets; an accounting policy election can be made to adjust the effective interest rate for existing troubled debt restructurings based on the prepayment assumptions instead of the prepayment assumptions applicable immediately prior to the restructuring event; and extends the practical expedient to exclude accrued interest receivable from all additional relevant disclosures involving amortized cost basis. The effective dates in this Update are the same as those applicable for ASU 2019-10. The Company qualifies as a smaller reporting company and does not expect to early adopt these ASUs.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740), to simplify the accounting for income taxes, change the accounting for certain tax transactions, and make minor improvements to the codification. This Update provides a policy election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax and provides guidance to evaluate whether a step-up in tax basis of goodwill relates to a business combination in which book goodwill was recognized or was a separate transaction. The Update also changes current guidance for making an intraperiod allocation if there is a loss in continuing operations and gains outside of continuing operations, determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting, accounting for tax law changes and year-to-date losses in interim periods, and determining how to apply the income tax guidance to franchise taxes that are partially based on income. For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. This Update is not expected to have a significant impact on the Company’s financial statements.

In March 2020, the FASB issued ASU 2020-3, Codification Improvements to Financial Instruments. This ASU was issued to improve and clarify various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016. The ASU includes seven issues that describe the areas of improvement and the related amendments to GAAP; they are intended to make the standards easier to understand and apply and to eliminate inconsistencies, and they are narrow in scope and are not expected to significantly change practice for most entities. Among its provisions, the ASU clarifies that all entities, other than public business entities that elected the fair value option, are required to provide certain fair value disclosures under ASC 825, Financial Instruments, in both interim and annual financial statements. It also clarifies that the contractual term of a net investment in a lease under Topic 842 should be the contractual term used to measure expected credit losses under Topic 326. Amendments related to ASU 2019-04 are effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. Early adoption is not permitted before an entity’s adoption of ASU 2016-01. Amendments related to ASU 2016-13 for entities that have not yet adopted that guidance are effective upon adoption of the amendments in ASU 2016-13. Early adoption is not permitted before an entity’s adoption of ASU 2016-13. Amendments related to ASU 2016-13 for entities that have adopted that guidance are effective for fiscal years beginning after December 15, 2019, including interim periods within those years. Other amendments are effective upon issuance of this ASU. The Company is currently evaluating the impact the adoption of the standard will have on the Company’s financial position or results of operations.

In January 2020, the FASB issued ASU 2020-4, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, March 2020, to provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as Secured Overnight Financing Rate. Entities can elect not to apply certain modification accounting requirements to contracts affected by what the guidance calls reference rate reform, if certain criteria are met. An entity that makes this election would not have to remeasure the contracts at the modification date or reassess a previous accounting determination. Also, entities can elect various optional expedients that would allow them to continue applying hedge accounting for hedging relationships affected by reference rate reform, if certain criteria are met, and can make a one-time election to sell and/or reclassify held-to-maturity debt securities that reference an interest rate affected by reference rate reform. The amendments in this ASU are effective for all entities upon issuance through December 31, 2022. It is too early to predict whether a new rate index replacement and the adoption of the ASU will have a material impact on the Company’s financial statements.

12. Acquisition of UpState New York Bancorp, Inc. and USNY Bank.

On January 8, 2020, the Company and the Bank, and UpState and its wholly owned subsidiary, USNY Bank entered into an Agreement and Plan of Merger (the “Merger Agreement”) pursuant to which UpState would merge with and into the Company, with the Company as the surviving corporation (“the Merger”). The Merger was completed on July 7, 2020. Pursuant to the terms of the Merger Agreement, UpState was merged with and into the Company, with the Company as the surviving corporation of the Merger. Immediately following the Merger, USNY Bank was merged with and into Wayne Bank, with Wayne Bank as the surviving entity.

USNY Bank conducted its business from two Bank of the Finger Lakes offices in Geneva and Penn Yan, New York, and two Bank of Cooperstown offices in Cooperstown and Oneonta, New York. At June 30, 2020, UpState had total assets of $463.8 million, total deposits of $412.8 million and total stockholders’ equity of $44.8 million.

Pursuant to the terms of the Merger Agreement, shareholders of UpState elected to receive for each share of UpState common stock they owned, either 0.9390 shares of the Company’s common stock or $33.33 in cash, or a combination of both. All shareholder elections were subject to the allocation and proration procedures set forth in the Merger Agreement which were intended to ensure that 90% of the shares of UpState would be exchanged for the Company’s common stock and 10% of the shares of UpState would be exchanged for cash. In addition, under the terms of the Merger Agreement, UpState shareholders received an additional $0.67 per share in cash for each share of UpState common stock held. In the aggregate, the merger consideration paid to UpState shareholders consisted of approximately $8,845,198 in cash and 1,865,738 shares of the Company’s common stock.

The senior management of the Company and Wayne Bank remained the same following the completion of the Merger. UpState directors Jeffrey S. Gifford and Alexandra K. Nolan have been appointed to the boards of directors of the Company and Wayne Bank. In addition, the remaining former directors of UpState have been invited to join a regional advisory board. UpState President and CEO R. Michael Briggs has entered into a consulting agreement with Wayne Bank. The Company has retained the brand names of USNY Bank’s two units, Bank of the Finger Lakes and Bank of Cooperstown, and has also retained USNY Bank’s administration center in Geneva, New York. Scott D. White, unit President of Bank of Cooperstown, and Jeffrey E. Franklin, unit President of Bank of the Finger Lakes, will also remain in place as executives of their units.

The acquired assets and assumed liabilities were measured at estimated fair values. Management made significant estimates and exercised significant judgement in accounting for the acquisition. Management measured loan fair values based on loan file reviews, appraised collateral values, expected cash flows, and historical loss factors. The Company also recorded and identifiable asset representing the core deposit base of UpState based on management’s evaluation of the cost of such deposits relative to alternative funding sources. Management used significant estimates including the average lives of depository accounts, future interest rate levels, and the cost of servicing various depository products. Management used market quotations to determine the fair value of investment securities.

The business combination resulted in the acquisition of loans with and without evidence of credit quality deterioration. UpState loans were deemed impaired at the acquisition date if the Company did not expect to receive all contractually required cash flows due to concerns about credit quality. Such loans were fair valued and the difference between contractually required payments at the acquisition date and cash flows expected to be collected was recorded as a non-accretable difference. At the acquisition date, the Company recorded $15,410,000 of purchased credit-impaired loans subject to a non-accretable difference of $5,213,000. The method of measuring carrying value of purchased loans differs from loans originated by the Company (originated loans), and as such, the Company identifies purchased loans and purchased loans with a credit quality discount and originated loans at amortized cost.

UpState’s loans without evidence of credit deterioration were fair valued by discounting both expected principal and interest cash flows using an observable discount rate for similar instruments that a market participant would consider in determining fair value. Additionally, consideration was given to management’s best estimates of default rates and payment speeds. At acquisition, UpState’s loan portfolio without evidence of deterioration totaled $400,127,000 and was recorded at a fair value of $393,580,000.

The following table summarizes the purchase of UpState as of July 7, 2020:



(Dollars in Thousands, Except Per Share Data)

Purchase Price Consideration in Common Stock
UpState New York Bancorp, Inc. common shares settled for stock		1,987,206
Exchange Ratio		0.9390
Norwood Financial Corp shares issued		1,865,738
Value assigned to each Norwood Financial Corp common share	$	24.30
Purchase price assigned to UpState New York Bancorp, Inc. common shares			$	45,337
exchanged for Norwood Financial Corp shares

Purchase Price Consideration - Cash for Common Stock
UpState New York Bancorp, Inc. shares exchanged for cash, excluding fractional shares		220,794
Purchase price paid to each UpState New York Bancorp, Inc. common share exchanged for cash	$	33.33
Purchase price assigned to UpState New York Bancorp, Inc. common shares exchanged for cash			$	7,359
Purchase price additional cash consideration per share				1,479
Purchase price consideration - Cash-in-lieu of Fractional Shares				6
Total Purchase Price			$	54,181

Net Assets Acquired:

UpState New York Bancorp, Inc. shareholders' equity	$	44,803
UpState New York Bancorp, Inc. goodwill and intangibles		-
Total tangible equity		44,803

Adjustments to reflect assets acquired at fair value:
Investments		(112)
Loans
Interest rate		3,982
General credit		(10,529)
Specific credit - non-amortizing		(5,213)
Specific credit - amortizing		(1,724)
Core deposit intangible		409
Deferred loan fees		(812)
Premises and equipment		(1,211)
Allowance for loan and lease losses		5,982
Deferred tax assets		2,526
Other		(48)

Adjustments to reflect liabilities acquired at fair value:
Time deposits		(2,754)

Net assets acquired				35,299
Goodwill resulting from merger			$	18,882

The following condensed statement reflects the values assigned to UpState New York Bancorp, Inc. net assets as of the acquisition date:



(In Thousands)

Total purchase price			$	54,181

Net assets acquired:
Cash	$	24,037
Securities available for sale		13,836
Loans		405,221
Premises and equipment, net		4,318
Regulatory stock		2,487
Accrued interest receivable		1,426
Core deposit intangible		564
Other assets		4,194
Deposits		(414,113)
Accrued interest payable		(175)
Other liabilities		(6,496)
Total identifiable net assets acquired				35,299

Goodwill resulting from UpState New York Bancorp, Inc. Merger			$	18,882

The Company recorded goodwill and other intangibles associated with the acquisition of UpState New York Bancorp, Inc. totaling $19,291,000. Goodwill is not amortized, but is periodically evaluated for impairment. The Company did not recognize any impairment during the nine months ended September 30, 2020. The carrying amount of the goodwill at September 30, 2020 related to the UpState acquisition was $18,882,000.

Identifiable intangibles are amortized to their estimated residual values over the expected useful lives. Such lives are also periodically reassessed to determine if any amortization period adjustments are required. During the nine months ended September 30, 2020, no such adjustments were recorded. The identifiable intangible assets consist of a core deposit intangible which is being amortized on an accelerated basis over the useful life of such asset. The gross carrying amount of the core deposit intangible at September 30, 2020 was $409,000 with $19,000 accumulated depreciation as of that date.

As of September 30, 2020, the current year and estimated future amortization expense for the core deposit intangible associated with the UpState acquisition is:


(In thousands)

2020	$	37
2021		71
2022		63
2023		56
2024		48
After five years		134
	$	409

The following table presents financial information for the former UpState included in the Consolidated Statements of Income from the date of acquisition through September 30, 2020:


		Actual From
		Acquisition Date
		Through
		September 30,2020
		(in thousands)

Net interest income after provision for loan losses	$	3,522
Noninterest income	$	151

The following table presents pro forma information for the nine and three-month periods ended September 30, 2020 and 2019, as if the acquisition of UpState had occurred on January 1, 2019. This table has been prepared for comparative purposes only, and is not indicative of the actual results that would have been attained had the acquisition occurred as of the beginning of the periods presented, nor is it indicative of future results:




	Pro Forma				Pro Forma
	Nine Months Ended September 30,				Three Months Ended September 30,
(In Thousands, Except Per Share Data)	2020		2019		2020		2019
Net interest income after provision for loan losses	$	38,632	$	38,658	$	13,480	$	13,236
Noninterest income		5,443		5,704		2,072		2,089
Net income		14,434		14,759		5,304		5,287
Pro forma earnings per share:
Basic	$	1.80	$	1.84	$	0.66	$	0.66
Diluted	$	1.79	$	1.83	$	0.66	$	0.66

13. Risks and Uncertainties

The Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was signed into law on March 27, 2020, and provided over $2.0 trillion in emergency economic relief to individuals and businesses impacted by the COVID-19 pandemic. The CARES Act authorized the Small Business Administration (“SBA”) to temporarily guarantee loans under a new 7(a) loan program called the Paycheck Protection Program (“PPP”). As a qualified SBA lender, we were automatically authorized to originate PPP loans.

An eligible business can apply for a PPP loan up to the greater of: (1) 2.5 times its average monthly payroll costs; or (2) $10.0 million. PPP loans will have: (a) an interest rate of 1.0%, (b) a two-year or five-year loan term to maturity; and (c) principal and interest payments deferred for ten months from the end of the coverage period. The SBA will guarantee 100% of the PPP loans made to eligible borrowers. The entire principal amount of the borrower’s PPP loan, including any accrued interest, is eligible to be reduced by the loan forgiveness amount under the PPP so long as employee and compensation levels of the business are maintained and 60% of the loan proceeds are used for payroll expenses, with the remaining 40% of the loan proceeds used for other qualifying expenses. As of September 30, 2020, the Company approved 1,138 applications for $95.0 million of loans under the PPP.

Since the opening of the PPP, several larger banks have been subject to litigation regarding the process and procedures that such banks used in processing applications for the PPP. Norwood may be exposed to the risk of similar litigation, from both customers and non-customers that approached the bank regarding PPP loans, regarding the process and procedures used in processing applications for the PPP. If any such litigation is filed against and is not resolved in a manner favorable to Norwood, it may result in significant financial liability or adversely affect reputation. In addition, litigation can be costly, regardless of outcome. Any financial liability, litigation costs or reputational damage caused by PPP-related litigation could have a material adverse impact on our business, financial condition and results of operations.

The Company also has credit risk on PPP loans if a determination is made by the SBA that there is a deficiency in the manner in which the loan was originated, funded, or serviced by, such as an issue with the eligibility of a borrower to receive a PPP loan, which may or may not be related to the ambiguity in the laws, rules and guidance regarding the operation of the PPP. In the event of a loss resulting from a default on a PPP loan and a determination by the SBA that there was a deficiency in the manner in which the PPP loan was originated, funded, or serviced by the Company , the SBA may deny its liability under the guaranty, reduce the amount of the guaranty, or, if it has already paid under the guaranty, seek recovery of any loss related to the deficiency from the Company.

COVID-19 Loan Forbearance Programs. Section 4013 of the CARES Act provides that banks may elect not to categorize a loan modification as a TDR if the loan modification is (1) related to COVID-19; (2) executed on a loan that was not more than 30 days past due as of December 31, 2019; and (3) executed between March 1, 2020, and the earlier of (A) 60 days after the date on which the national emergency concerning the novel coronavirus disease (COVID–19) outbreak declared by the President on March 13, 2020, under the National Emergencies Act terminates, or (B) December 31, 2020. According to the Interagency Statement on Loan

Modifications and Reporting for Financial Institutions Working with Customers Affected by the Coronavirus (Revised) issued by the federal bank regulatory agencies on April 7, 2020, short-term loan modifications not otherwise eligible under Section 4013 that are made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief are not TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. See Note 8 of the financial statements for additional disclosure of TDRs at September 30, 2020.

The following table presents a summary of loans that were granted forbearance by type of loan during the nine-months ended September 30, 2020:


Loan Type	Number of ‎Loans		Balance ‎(in thousands)
Real Estate Loans:
Residential		117	$	10,723
Commercial		384		218,891
Agricultural		16		5,267
Construction		24		4,125
Commercial, financial and agricultural		183		23,677
Other agricultural loans		—		—
Consumer loans to individuals		467		10,682
Total		1,191	$	273,365

The following table presents a summary of loans that remain in forbearance by type of loan as of September 30, 2020:


Loan Type	Number of ‎Loans		Balance ‎(in thousands)
Real Estate Loans:
Residential		13	$	1,660
Commercial		162		102,018
Agricultural		12		5,025
Construction		2		982
Commercial, financial and agricultural		88		15,672
Other agricultural loans		—		—
Consumer loans to individuals		37		920
Total		314	$	126,277

‎

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 contains safe harbor provisions regarding forward-looking statements. When used in this discussion, the words “believes,” “anticipates,” “contemplates,” “expects,” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties which could cause actual results to differ materially from those projected. Those risks and uncertainties include:

possible future impairment of intangible assets

our ability to effectively manage future growth

loan losses in excess of our allowance

the impact of the COVID-19 pandemic on us

risk of litigation from participation in the PPP loan program

risks inherent in the COVID-19 loan forbearance programs under the CARES Act

risks inherent in commercial lending

real estate collateral which is subject to declines in value

potential other-than-temporary impairments

soundness of other financial institutions

interest rate risks

potential liquidity risk

deposits acquired through competitive bidding

availability of capital

regional economic factors

loss of senior officers

comparatively low legal lending limits

risks of new capital requirements

potential impact of Tax Cuts and Jobs Act

limited market for the Company’s stock

restrictions on ability to pay dividends

common stock may lose value

insider ownership

issuing additional shares may dilute ownership

competitive environment

certain anti-takeover provisions

extensive and complex governmental regulation and associated cost

cybersecurity

The Company undertakes no obligation to publicly release the results of any revisions to those forward-looking statements which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Critical Accounting Policies

Note 2 to the Company’s consolidated financial statements for the year ended December 31, 2019 (incorporated by reference in Item 8 of the Annual Report on Form 10-K for the fiscal year ended December 31, 2019) lists significant accounting policies used in the development and presentation of its financial statements. This discussion and analysis, the significant accounting policies, and other financial statement disclosures identify and address key variables and other qualitative and quantitative factors that are necessary for an understanding and evaluation of the Company and its results of operations.

Material estimates that are particularly susceptible to significant change in the near term relate to the determination of the allowance for loan losses, the valuation of deferred tax assets, the fair value of financial instruments, the determination of other-than-

temporary impairment on securities and the determination of goodwill impairment. Please refer to the discussion of the allowance for loan losses calculation under “Loans” in the “Changes in Financial Condition” section.

The Company uses the modified prospective transition method to account for stock options. Under this method companies are required to record compensation expense, based on the fair value of options over the vesting period. Restricted shares vest over a five-year period. The product of the number of shares granted and the grant date market price of the Company’s common stock determines the fair value of restricted stock.

Deferred income taxes reflect temporary differences in the recognition of the revenue and expenses for tax reporting and financial statement purposes, principally because certain items are recognized in different periods for financial reporting and tax return purposes. Although realization is not assured, the Company believes that it is more likely than not that all deferred tax assets will be realized.

The fair value of financial instruments is based upon quoted market prices, when available. For those instances where a quoted price is not available, fair values are based upon observable market based parameters as well as unobservable parameters. Any such valuation is applied consistently over time.

Management determines the appropriate classification of debt securities at the time of purchase and re-evaluates such designation as of each Consolidated Balance Sheet date.

Declines in the fair value of available for sale securities below their cost that are deemed to be other than temporary are reflected in earnings as realized losses. In estimating other-than-temporary impairment losses, the Company considers (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent of the Company to not sell the securities and whether it is more likely than not that it will not have to sell the securities before recovery of their cost basis. The Company believes that all unrealized losses on securities at September 30, 2020 and December 31, 2019 represent temporary impairment of the securities, related to changes in interest rates.

In connection with acquisitions, the Company recorded goodwill in the amount of $30.2 million, representing the excess of amounts paid over the fair value of net assets of the institutions acquired in purchase transactions, at its fair value at the date of acquisition. Goodwill is tested and deemed impaired when the carrying value of goodwill exceeds its implied fair value. The value of the goodwill can change in the future. We expect the value of the goodwill to decrease if there is a significant decrease in the franchise value of the Company or the Bank. If an impairment loss is determined in the future, we will reflect the loss as an expense for the period in which the impairment is determined, leading to a reduction of our net income for that period by the amount of the impairment loss.

Changes in Financial Condition

General

Total assets as of September 30, 2020 were $1.842 billion compared to $1.231 billion as of December 31, 2019. The increase was due primarily to the $456.1 million of assets acquired in the UpState merger. The increase in total assets and loans outstanding is also due in part to the Company’s participation in the PPP and other related economic stimulus programs.

Securities

The fair value of securities available for sale as of September 30, 2020 was $197.4 million compared to $210.2 million as of December 31, 2019. The decrease in the securities portfolio is the result of sales, calls, maturities and principal reductions of securities with the proceeds utilized to fund loan growth.

The carrying value of the Company’s securities portfolio (Available-for Sale) consisted of the following:



	September 30, 2020				December 31, 2019
(dollars in thousands)		Amount	% of portfolio			Amount	% of portfolio
States and political subdivisions	$	53,065	26.9	%	$	71,305	33.9	%
Corporate obligations		3,063	1.5			4,100	2.0
Mortgage-backed securities-
government sponsored entities		141,308	71.6			134,800	64.1
Total	$	197,436	100.0	%	$	210,205	100.0	%

The Company has securities in an unrealized loss position. In management’s opinion, the unrealized losses reflect changes in interest rates subsequent to the acquisition of specific securities. Management believes that the unrealized losses on all holdings represent temporary impairment of the securities, as the Company has the intent and ability to hold these investments until maturity or market price recovery.

Loans

Loans receivable totaled $1.415 billion at September 30, 2020 compared to $924.6 million as of December 31, 2019. The increase in loans receivable includes $402.2 million of loans acquired in the UpState merger. The loan growth recorded during the first nine months of 2020 also includes $95.0 million of PPP loans. Organic loan growth for the nine-month period ended September 30, 2020 was negatively impacted by the effects of the COVID-19 pandemic as social distancing constraints and business closures resulted in a significant slowing of new loan originations.

The allowance for loan losses totaled $11,674,000 as of September 30, 2020, and represented 0.83% of total loans outstanding, compared to $8.5 million, or 0.92% of total loans, at December 31, 2019. The Company had net charge-offs for the nine months ended September 30, 2020 of $685,000 compared to $1,097,000 in the corresponding period in 2019. The Company’s management assesses the adequacy of the allowance for loan losses on a quarterly basis. The process includes an analysis of the risks inherent in the loan portfolio. It includes an analysis of impaired loans and a historical review of credit losses by loan type. Other factors considered include concentration of credit in specific industries, economic and industry conditions, trends in delinquencies and loan classifications, and loan growth. In addition, management has included qualitative factors during 2020 which are specifically related to the economic impact of the COVID-19 pandemic. Management considers the allowance adequate at September 30, 2020 based on the Company’s criteria. However, there can be no assurance that the allowance for loan losses will be adequate to cover significant losses, if any, that might be incurred in the future.

As of September 30, 2020, non-performing loans totaled $12.6 million, or 0.89% of total loans compared to $795,000, or 0.09%, of total loans at December 31, 2019. The increase reflects loans acquired in the UpState merger. At September 30, 2020, non-performing assets totaled $13.6 million, or 0.74%, of total assets, compared to $2.4 million, or 0.19%, of total assets at December 31, 2019.

The following table sets forth information regarding non-performing loans and foreclosed real estate at the dates indicated:



(dollars in thousands)	September 30, 2020			December 31, 2019
Loans accounted for on a non-accrual basis:
Real Estate
Residential	$	663		$	567
Commercial		1,280			99
Agricultural		676
Construction		—			—
Commercial and financial loans		23			50
Other agricultural loans		263
Consumer loans to individuals		139			79
Total non-accrual loans *		3,044			795
Accruing loans which are contractually
past due 90 days or more		1,000			—
Total non-performing loans		4,044			795
Foreclosed real estate		965			1,556
Total non-performing assets	$	5,009		$	2,351

Purchased credit impaired loans (a)	$	8,586		$	696

Allowance for loans losses	$	11,674		$	8,509

Coverage of non-performing loans (a) (b)		289%	%		1,070%	%
Non-performing loans to total loans(a)		0.29	%		0.09	%
Non-performing loans to total assets(a)		0.22	%		0.06	%
Non-performing assets to total assets(a)		0.27	%		0.19	%

*Includes non-accrual TDRs of $91,000 as of September 30, 2020 and $99,000 as of December 31, 2019. There were no accruing TDRs as of September 30, 2020 or as of December 31, 2019.

(a) Purchased impaired loans are loans obtained in acquisition transactions that as of the acquisition date were specifically identified as displaying signs of credit deterioration and for which the Company did not expect to collect all contractually required principal and interest payments. Those loans were impaired at the date of acquisition, were recorded at estimated fair value and were generally delinquent in payments. The Company estimated the timing and amount of expected cash flows in excess of the estimated fair value and established an accretable discount on the acquisition date relating to these impaired loans that is recognized in interest income.

(b) For loans acquired with specific evidence of deterioration in credit quality, a specific credit fair value adjustment is established at the date of acquisition and will not impact the allowance for loan losses unless actual losses exceed the established fair value adjustment.

During the nine-months ended September 30, 2020, over 1,100 of our loan customers had requested loan payment deferrals or payments of interest only on loans totaling $273.4 million. In accordance with interagency guidance issued in March 2020, these short-term deferrals are not considered troubled debt restructurings (“TDRs”) unless the borrower was previously experiencing financial difficulty.

In addition, the risk-rating on COVID-19 modified loans did not change, and these loans will not be considered past due until after the deferral period is over and scheduled payments resume. The credit quality of these loans will be reevaluated after the deferral period ends.

Deposits

During the nine-month period ended September 30, 2020, total deposits increased $558.4 million due primarily to the $414.1 million of deposits acquired in the UpState merger. The increase during the 2020 period also includes the impact from the PPP and other economic stimulus programs.

The following table sets forth deposit balances as of the dates indicated:



(dollars in thousands)	September 30, 2020		December 31, 2019
Non-interest bearing demand	$	372,237	$	207,299
Interest-bearing demand		157,927		99,366
Money market deposit accounts		229,941		128,441
Savings		220,640		161,705
Time deposits <$100,000		205,671		143,940
Time deposits >$100,000		329,506		216,778
Total	$	1,515,922	$	957,529

Borrowings

Other borrowings as of September 30, 2020, totaled $46.4 million compared to $56.4 million as of December 31, 2019. Short-term borrowings, which consist of securities sold under agreements to repurchase and overnight borrowings from the FHLB, increased $7.0 million due to a $38.8 million increase in repurchase agreements, which was partially offset by a $31.8 million reduction in overnight borrowings.

Other borrowings consisted of the following:



(dollars in thousands)	September 30, 2020		December 31, 2019
Notes with the FHLB:
Fixed rate term borrowing due May 2020 at 1.85%	$	—	$	5,000
Amortizing fixed rate borrowing due June 2020 at 1.490%		—		1,034
Amortizing fixed rate borrowing due July 2020 at 2.77%		—		2,974
Amortizing fixed rate borrowing due December 2020 at 1.706%		260		2,538
Amortizing fixed rate borrowing due December 2020 at 3.06%		642		1,034
Amortizing fixed rate borrowing due March 2022 at 1.748%		1,348		2,009
Amortizing fixed rate borrowing due August 2022 at 1.94%		3,874		5,351
Amortizing fixed rate borrowing due October 2022 at 1.88%		3,425		4,626
Amortizing fixed rate borrowing due October 2023 at 3.24%		6,357		7,809
Amortizing fixed rate borrowing due December 2023 at 3.22%		3,341		4,063
Fixed rate term borrowing due December 2023 at 1.95%		10,000		10,000
Amortizing fixed rate borrowing due December 2023 at 1.73%		8,216		10,000
Amortizing fixed rate borrowing due April 2024 at 0.91%		8,975		—
	$	46,438	$	56,438

Stockholders’ Equity and Capital Ratios

As of September 30, 2020, stockholders’ equity totaled $190.5 million, compared to $137.4 million as of December 31, 2019. The net change in stockholders’ equity included $45.3 million resulting from the UpState merger and $9.6 million of net income, which was partially offset by $5.7 million of dividends declared. In addition, total equity increased $3.5 million due to an increase in the fair value of securities in the available for sale portfolio, net of tax. This increase in fair value is the result of a change in interest rates and spreads, which may impact the value of the securities. Because of interest rate volatility, the Company’s accumulated other comprehensive income could materially fluctuate for each interim and year-end period.

A comparison of the Company’s consolidated regulatory capital ratios is as follows:



	September 30, 2020	December 31, 2019
Tier 1 Capital
(To average assets)	8.80%	10.18%
Tier 1 Capital
(To risk-weighted assets)	11.52%	13.11%
Common Equity Tier 1 Capital
(To risk-weighted assets)	11.52%	13.11%
Total Capital
(To risk-weighted assets)	12.40%	14.01%

Effective January 1, 2015, the Company and the Bank became subject to new regulatory capital rules, which, among other things, impose a new common equity Tier 1 minimum capital requirement (4.5% of risk-weighted assets), set the minimum leverage ratio for all banking organizations at a uniform 4% of total assets, increase the minimum Tier 1 capital to risk-based assets requirement (from 4% to 6% of risk-weighted assets) and assign a higher risk weight (150%) to exposures that are more than 90 days past due or are on nonaccrual status and to certain commercial real estate facilities that finance the acquisition, development or construction of real property. The new rules also require unrealized gains and losses on certain “available-for-sale” securities holdings to be included for purposes of calculating regulatory capital requirements unless a one-time opt out is exercised which the Company and the Bank have done. The final rule limits a banking organization’s dividends, stock repurchases and other capital distributions, and certain discretionary bonus payments to executive officers, if the banking organization does not hold a “capital conservation buffer” consisting of 2.5% of common equity Tier 1 capital to risk-weighted assets above regulatory minimum risk-based requirements. The capital conservation buffer requirement was phased in beginning January 1, 2016 and ending January 1, 2019, when the full capital conservation buffer requirement became effective. The Company and the Bank are in compliance with their respective new capital requirements, including the capital conservation buffer, as of September 30, 2020.

Liquidity

As of September 30, 2020, the Company had cash and cash equivalents of $124.4 million in the form of cash, due from banks and short-term deposits with other institutions. In addition, the Company had total securities available for sale of $197.4 million which could be used for liquidity needs. This totals $321.9 million of liquidity and represents 17.5% of total assets compared to $225.6 million and 18.3% of total assets as of December 31, 2019. The Company also monitors other liquidity measures, all of which were within the Company’s policy guidelines as of September 30, 2020 and December 31, 2019. Based upon these measures, the Company believes its liquidity is adequate.

Capital Resources

The Company has a line of credit commitment from Atlantic Community Bankers Bank for $7,000,000 which expires June 30, 2021. There were no borrowings under this line as of September 30, 2020 and December 31, 2019.

The Company has a line of credit commitment available which has no stated expiration date from PNC Bank for $16,000,000. There were no borrowings under this line as of September 30, 2020 and December 31, 2019.

The Company has a line of credit commitment available which has no stated expiration date from Zions Bank for $17,000,000. There were no borrowings under this line as of September 30, 2020 and December 31, 2019.

The Bank’s maximum borrowing capacity with the Federal Home Loan Bank was approximately $429,045,000 as of September 30, 2020, of which $46,437,000 was outstanding in the form of borrowings. As of December 31, 2019, the maximum borrowing capacity was $425,226,000, of which $88,189,000 of borrowings was outstanding. Additionally, as of September 30, 2020, the Bank had secured Letters of Credit from the Federal Home Loan Bank in the amount of $152.4 million as collateral for specific municipal deposits. These Letters of Credit reduce the availability under the maximum borrowing capacity. There was $56,000,000 outstanding in the form of Letters of Credit as of December 31, 2019. Advances and Letters of Credit from the Federal Home Loan Bank are secured by qualifying assets of the Bank.

Non-GAAP Financial Measures

This report contains or references fully taxable-equivalent (fte) interest income and net interest income, which are non-GAAP financial measures. Interest income (fte) and net interest income (fte) are derived from GAAP interest income and net interest income using an assumed tax rate of 21%. We believe the presentation of interest income (fte) and net interest income (fte) ensures comparability of interest income and net interest income arising from both taxable and tax-exempt sources and is consistent with industry practice. Interest income (fte) and Net interest income (fte) is reconciled to GAAP interest income and net interest income on pages 41 and 45. Although the Company believes that these non-GAAP financial measures enhance investors’ understanding of our business and performance, these non-GAAP financial measures should not be considered an alternative to GAAP measures.

Results of Operations

NORWOOD FINANCIAL CORP

Consolidated Average Balance Sheets with Resultant Interest and Rates



(Tax-Equivalent Basis,	Three Months Ended September 30,
dollars in thousands)	2020						2019
	Average				Average		Average				Average
	Balance		Interest		Rate		Balance		Interest		Rate
	(2)		(1)		(3)		(2)		(1)		(3)
Assets
Interest-earning assets:
Interest-bearing deposits with banks	$	78,525	$	18		0.09%	$	693	$	5		2.89%
Securities available for sale:
Taxable		147,864		687		1.86		147,079		798		2.17
Tax-exempt (1)		50,543		436		3.45		80,099		608		3.04
Total securities available for sale (1)		198,407		1,123		2.26		227,178		1,406		2.48
Loans receivable (1) (4) (5)		1,391,012		16,385		4.71		897,850		10,890		4.85
Total interest-earning assets		1,667,944		17,526		4.20		1,125,721		12,301		4.37
Non-interest earning assets:
Cash and due from banks		23,036						14,968
Allowance for loan losses		(10,894)						(8,344)
Other assets		106,437						83,474
Total non-interest earning assets		118,579						90,098
Total Assets	$	1,786,523					$	1,215,819
Liabilities and Stockholders' Equity
Interest-bearing liabilities:
Interest-bearing demand and money market	$	360,183	$	192		0.21	$	232,893	$	173		0.30
Savings		219,441		34		0.06		168,972		26		0.06
Time		537,146		1,450		1.08		348,890		1,588		1.82
Total interest-bearing deposits		1,116,770		1,676		0.60		750,755		1,787		0.95
Short-term borrowings		58,527		61		0.42		56,136		135		0.96
Other borrowings		48,415		242		2.00		39,349		246		2.50
Total interest-bearing liabilities		1,223,712		1,979		0.65		846,240		2,168		1.02
Non-interest bearing liabilities:
Demand deposits		356,827						218,893
Other liabilities		21,859						16,649
Total non-interest bearing liabilities		378,686						235,542
Stockholders' equity		184,125						134,037
Total Liabilities and Stockholders' Equity	$	1,786,523					$	1,215,819
Net interest income/spread (tax equivalent basis)				15,547		3.55%				10,133		3.35%
Tax-equivalent basis adjustment				(217)						(242)
Net interest income			$	15,330					$	9,891
Net interest margin (tax equivalent basis)						3.73%						3.60%

(1)Interest and yields are presented on a tax-equivalent basis using a marginal tax rate of 21%.

(2)Average balances have been calculated based on daily balances.

(3)Annualized

(4)Loan balances include non-accrual loans and are net of unearned income.

(5)Loan yields include the effect of amortization of deferred fees, net of costs.

Rate/Volume Analysis. The following table shows the fully taxable equivalent effect of changes in volumes and rates on interest income and interest expense.




	Increase/(Decrease)
	Three months ended September 30, 2020 Compared to
	Three months ended September 30, 2019
	Variance due to
	Volume		Rate		Net

	(dollars in thousands)
Interest-earning assets:
Interest-bearing deposits with banks	$	35	$	(22)	$	13
Securities available for sale:
Taxable		4		(115)		(111)
Tax-exempt securities		(229)		57		(172)
Total securities		(225)		(58)		(283)
Loans receivable		5,968		(473)		5,495
Total interest-earning assets		5,778		(553)		5,225
Interest-bearing liabilities:
Interest-bearing demand and money market		82		(63)		19
Savings		8		—		8
Time		631		(769)		(138)
Total interest-bearing deposits		721		(832)		(111)
Short-term borrowings		3		(77)		(74)
Other borrowings		51		(55)		(4)
Total interest-bearing liabilities		775		(964)		(189)
Net interest income (tax-equivalent basis)	$	5,003	$	411	$	5,414

Changes in net interest income that could not be specifically identified as either a rate or volume change were allocated proportionately to changes in volume and changes in rate.

‎

Comparison of Operating Results for the Three Months Ended September 30, 2020 to September 30, 2019

General

For the three months ended September 30, 2020, net income totaled $4,999,000 compared to $3,907,000 earned in the similar period in 2019. The increase in net income for the three months ended September 30, 2020 was due primarily to a $5,439,000 million improvement in net interest income which reflects the benefits realized from the merger of UpState. This increase was partially offset by an increase in the provision for loan losses and $386,000 of merger related expenses. Earnings per share for the three-months ended September 30, 2020 were $0.62 per share for basic shares and fully diluted shares compared to $0.62 per share for basic shares and fully diluted shares for the three months ended September 30, 2019. The resulting annualized return on average assets and annualized return on average equity for the three months ended September 30, 2020 were 1.11% and 10.64%, respectively, compared to 1.27% and 11.56%, respectively, for the same period in 2019.

The following table sets forth changes in net income:



(dollars in thousands)	Three months ended
	September 30, 2020 to September 30, 2019
Net income three months ended September 30, 2019	$	3,907
Change due to:
Net interest income		5,439
Provision for loan losses		(1,550)
Net gains on sales		13
Other income		177
Salaries and employee benefits		(1,145)
Occupancy, furniture and equipment		(193)
Data processing related		(266)
FDIC insurance assessment		(149)
Merger related		(386)
All other expenses		(450)
Income tax expense		(398)
Net income three months ended September 30, 2020	$	4,999

Net Interest Income

Net interest income on a fully taxable equivalent basis (fte) for the three months ended September 30, 2020 totaled $15,547,000 which was $5,414,000 higher than the comparable period in 2019. The increase in net interest income was due primarily to a $5,495,000 increase in interest income (fte) on loans resulting from the acquisition of UpState. Tax-equivalent interest income was negatively impacted by a $283,000 decrease in securities income. The fte net interest spread and net interest margin were 3.55% and 3.73%, respectively, for the three months ended September 30, 2020 compared to 3.35% and 3.60%, respectively, for the same period in 2019. The increase in the net interest spread reflects the growth in average interest-earning assets.

For the three-months ended September 30, 2020, interest income (fte) totaled $17,526,000 with a yield on average earning assets of 4.20% compared to $12,301,000 and 4.37% for the 2019 period. Average loans increased $493.2 million during the three-months ended September 30, 2020, over the comparable period of 2019, while average securities decreased $28.8 million as portfolio runoff was utilized to fund loan growth. Average earning assets totaled $1.668 billion for the three months ended September 30, 2020, an increase of $542.2 million over the average for the same period in 2019. All increases reflect growth resulting from the merger with UpState.

Interest expense for the three months ended September 30, 2020 totaled $1,979,000 at an average cost of 0.65% compared to $2,168,000 and 1.02% for the same period in 2019. The decrease in average cost during the 2020 quarter reflects the overall lower level of interest rates. The average cost of time deposits, which is the most significant component of funding, decreased 0.74% during the period.

Provision for Loan Losses

The Company’s provision for loan losses for the three months ended September 30, 2020 was $1,850,000 compared to $300,000 for the three months ended September 30, 2019. The increased provision includes the increased risk related to the economic impact of the COVID-19 pandemic. The Company makes provisions for loan losses in an amount necessary to maintain the

allowance for loan losses at an acceptable level. Net charge-offs were $488,000 for the quarter ended September 30, 2020, compared to $123,000 for the similar period in 2019. At September 30, 2020, the allowance for loan losses represented 0.83% of loans receivable. Additionally, the allowance for loan losses represented 289% of non-performing loans, excluding loans acquired with credit quality deterioration.

Other Income

Other income totaled $2,072,000 for the three months ended September 30, 2020, compared to $1,882,000 for the same period in 2019. The increase was due primarily to a $101,000 increase in service charges and fees. Net gains from the sale of securities totaled $33,000 for the three-months ended September 30, 2020, compared to $169,000 in the three-months ended September 30, 2019. Net gains on the sale of loans totaled $164,000 for the three-months ended September 30, 2020 compared to $15,000 in the three-months ended September 30, 2019.

Other Expense

Other expense for the three months ended September 30, 2020 totaled $9,380,000, which was $2,589,000 higher than the same period of 2019, due primarily to the $386,000 of merger related expenses and costs associated with the operation of four community offices acquired in the UpState merger.

Income Tax Expense

Income tax expense totaled $1,173,000 for an effective tax rate of 19.0% for the period ended September 30, 2020 compared to $775,000 for an effective tax rate of 16.6% for the similar period in 2019. The increase in the effective tax rate in the 2020 period reflects the merger costs and the related tax-deductions.

‎

Results of Operations

NORWOOD FINANCIAL CORP

Consolidated Average Balance Sheets with Resultant Interest and Rates



(Tax-Equivalent Basis,	Nine Months Ended September 30,
dollars in thousands)	2020						2019
	Average				Average		Average				Average
	Balance		Interest		Rate		Balance		Interest		Rate
	(2)		(1)		(3)		(2)		(1)		(3)
Assets
Interest-earning assets:
Interest bearing deposits with banks	$	51,705	$	43		0.11%	$	3,853	$	70		2.42%
Securities available for sale:
Taxable		144,582		2,182		2.01		152,404		2,545		2.23
Tax-exempt (1)		55,002		1,380		3.35		89,369		2,038		3.04
Total securities available for sale (1)		199,584		3,562		2.38		241,773		4,583		2.53
Loans receivable (1) (4) (5)		1,099,586		38,097		4.62		877,283		31,419		4.78
Total interest-earning assets		1,350,875		41,702		4.12		1,122,909		36,072		4.28
Non-interest earning assets:
Cash and due from banks		17,752						14,473
Allowance for loan losses		(9,692)						(8,472)
Other assets		93,351						79,743
Total non-interest earning assets		101,411						85,744
Total Assets	$	1,452,286					$	1,208,653
Liabilities and Stockholders' Equity
Interest-bearing liabilities:
Interest-bearing demand and money market	$	277,606	$	468		0.22	$	230,748	$	486		0.28
Savings		191,164		81		0.06		172,148		77		0.06
Time		427,351		4,547		1.42		356,222		4,792		1.79
Total interest-bearing deposits		896,121		5,096		0.76		759,118		5,355		0.94
Short-term borrowings		54,957		244		0.59		48,957		344		0.94
Other borrowings		52,287		824		2.10		45,059		827		2.45
Total interest-bearing liabilities		1,003,365		6,164		0.82		853,134		6,526		1.02
Non-interest bearing liabilities:
Demand deposits		274,297						210,900
Other liabilities		18,336						15,252
Total non-interest bearing liabilities		292,633						226,152
Stockholders' equity		156,288						129,367
Total Liabilities and Stockholders' Equity	$	1,452,286					$	1,208,653
Net interest income/spread (tax equivalent basis)				35,538		3.30%				29,546		3.26%
Tax-equivalent basis adjustment				(676)						(773)
Net interest income			$	34,862					$	28,773
Net interest margin (tax equivalent basis)						3.51%						3.51%

(1)Interest and yields are presented on a tax-equivalent basis using a marginal tax rate of 21%.

(2)Average balances have been calculated based on daily balances.

(3)Annualized

(4)Loan balances include non-accrual loans and are net of unearned income.

(5)Loan yields include the effect of amortization of deferred fees, net of costs.

Rate/Volume Analysis. The following table shows the fully taxable equivalent effect of changes in volumes and rates on interest income and interest expense



	Increase/(Decrease)
	Nine months ended September 30, 2020 Compared to
	Nine months ended September 30, 2019
	Variance due to
	Volume		Rate		Net
	(dollars in thousands)
Interest-earning assets:
Interest-bearing deposits with banks	$	75	$	(102)	$	(27)
Securities available for sale:
Taxable		(120)		(243)		(363)
Tax-exempt securities		(722)		64		(658)
Total securities		(842)		(179)		(1,021)
Loans receivable		6,998		(320)		6,678
Total interest-earning assets		6,231		(601)		5,630
Interest-bearing liabilities:
Interest-bearing demand and money market		88		(106)		(18)
Savings		4		—		4
Time		826		(1,071)		(245)
Total interest-bearing deposits		918		(1,177)		(259)
Short-term borrowings		29		(129)		(100)
Other borrowings		123		(126)		(3)
Total interest-bearing liabilities		1,070		(1,432)		(362)
Net interest income (tax-equivalent basis)	$	5,161	$	831	$	5,992

Comparison of Operating Results for the Nine Months Ended September 30, 2020 to September 30, 2019

General

For the nine months ended September 30, 2020, net income totaled $9,567,000 compared to $10,619,000 earned in the similar period in 2019. The decrease in net income for the nine months ended September 30, 2020 was due primarily to a $2,800,000 increase in the provision for loan losses and $1,983,000 of merger related expenses. Earnings per share for the current period were $1.39 per share for basic shares and fully diluted shares compared to $1.70 per share for basic shares and $1.68 per share for fully diluted shares for the nine months ended September 30, 2019. The resulting annualized return on average assets and annualized return on average equity for the nine months ended September 30, 2020 were 0.88% and 8.13%, respectively, compared to 1.17% and 10.97%, respectively, for the similar period in 2019.

The following table sets forth changes in net income:




(dollars in thousands)	Nine months ended
	September 30, 2020 to September 30, 2019
Net income nine months ended September 30, 2019	$	10,619
Change due to:
Net interest income		6,089
Provision for loan losses		(2,800)
Net gains on sales		(2)
Other income		38
Salaries and employee benefits		(963)
Occupancy, furniture and equipment		(203)
Data processing related		(249)
FDIC insurance assessment		(36)
Merger related		(1,983)
All other expenses		(873)
Income tax expense		(70)
Net income nine months ended September 30, 2020	$	9,567

Net Interest Income

Net interest income on a fully taxable equivalent basis (fte) for the nine months ended September 30, 2020 totaled $35,538,000 which was $5,992,000 higher than the comparable period in 2019. The increase in net interest income was due primarily to a $6,678,000 increase in interest income (fte) on loans resulting from the merger with UpState. Tax-equivalent interest income was negatively impacted by a $1,021,000 decrease in securities income. The fte net interest spread and net interest margin were 3.30% and 3.51%, respectively, for the nine months ended September 30, 2020 compared to 3.26% and 3.51%, respectively, for the similar period in 2019. The increase in the net interest spread reflects the growth in loans resulting from the UpState merger.

Interest income (fte) totaled $41,702,000 with a yield on average earning assets of 4.12% compared to $36,072,000 and 4.28% for the 2019 period. Average loans increased $222.3 million over the comparable period of last year, while average securities decreased $42.2 million as portfolio runoff was utilized to fund loan growth. Average earning assets totaled $1.351 billion for the nine months ended September 30, 2020, an increase of $228.0 million over the average for the similar period in 2019. All increases reflect assets acquired from UpState.

Interest expense for the nine months ended September 30, 2020 totaled $6,164,000 at an average cost of 0.82% compared to $6,526,000 and 1.02% for the similar period in 2019. The decrease in average cost reflects the overall lower level of interest rates. The average cost of time deposits, which is the most significant component of funding, decreased to 1.42 % from 1.79% for the similar period in the prior year.

Provision for Loan Losses

The Company’s provision for loan losses for the nine months ended September 30, 2020 was $3,850,000 compared to $1,050,000 for the nine months ended September 30, 2019. The increased provision includes the increased risk related to the economic impact of the COVID-19 pandemic. The Company makes provisions for loan losses in an amount necessary to maintain the allowance for loan losses at an acceptable level. Net charge-offs were $685,000 for the nine months ended September 30, 2020 compared to $1,097,000 for the similar period in 2019. At September 30, 2020, the allowance for loan losses represented 0.83% of loans receivable. Additionally, the allowance for loan losses represented 289% of non-performing loans, excluding loans acquired with credit quality deterioration.

Other Income

Other income totaled $5,119,000 for the nine months ended September 30, 2020 compared to $5,083,000 for the similar period in 2019. The increase was due primarily to a $79,000 increase related to fiduciary activities. All other items included in other income decreased $43,000, net. Net gains from the sale of securities totaled $71,000 for the nine-months ended September 30, 2020, compared to $233,000 in the nine-months ended September 30, 2019. Net gains on the sale of loans totaled $285,000 for the nine-months ended September 30, 2020 compared to $125,000 in the nine-months ended September 30, 2019.

Other Expense

Other expense for the nine months ended September 30, 2020 totaled $24,531,000 which was $4,307,000 higher than the same period of 2019 due primarily to $1,983,00 of merger related expenses and costs associated with the operation of four community offices acquired in the UpState merger.

Income Tax Expense

Income tax expense totaled $2,033,000 for an effective tax rate of 17.5% for the nine months ended September 30, 2020 compared to $1,963,000 for an effective tax rate of 15.6% for the similar period in 2019.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Market Risk

Interest rate sensitivity and the repricing characteristics of assets and liabilities are managed by the Asset and Liability Management Committee (ALCO). The principal objective of ALCO is to maximize net interest income within acceptable levels of risk, which are established by policy. Interest rate risk is monitored and managed by using financial modeling techniques to measure the impact of changes in interest rates.

Net interest income, which is the primary source of the Company’s earnings, is impacted by changes in interest rates and the relationship of different interest rates. To manage the impact of the rate changes, the balance sheet must be structured so that repricing opportunities exist for both assets and liabilities at approximately the same time intervals. The Company uses net interest simulation to assist in interest rate risk management. The process includes simulating various interest rate environments and their impact on net interest income. As of September 30, 2020, the level of net interest income at risk in a rising or declining 200 basis point change in interest rates was within the Company’s policy limits. The Company’s policy allows for a decline of no more than 10% of net interest income for a ± 200 basis point shift in interest rates.

Imbalance in repricing opportunities at a given point in time reflects interest-sensitivity gaps measured as the difference between rate-sensitive assets (RSA) and rate-sensitive liabilities (RSL). These are static gap measurements that do not take into account any future activity, and as such are principally used as early indications of potential interest rate exposures over specific intervals.

As of September 30, 2020, the Company had a positive 90-day interest sensitivity gap of $121.6 million or 6.6% of total assets, compared to the $5.9 million interest sensitivity gap, or 0.48% of total assets, as of December 31, 2019. Rate-sensitive assets repricing within 90 days increased $193.1 million due primarily to a $99.7 million increase in interest-bearing deposits and a $93.0 million increase in loans. Rate-sensitive liabilities repricing within 90 days increased $77.4 million since year end due to a $101.9 million increase in deposits repricing which was partially offset by a $24.6 million decrease in borrowings. A positive gap means that rate-sensitive assets are greater than rate-sensitive liabilities at the time interval. This would indicate that in a rising rate environment, yield on interest-earning assets in the 90-day time frame could increase faster than the cost of interest-bearing liabilities. The repricing intervals are managed by ALCO strategies, including adjusting the average life of the investment portfolio, pricing of deposit liabilities to attract longer term time deposits, loan pricing to encourage variable rate products and evaluation of loan sales of long-term fixed rate mortgages.

Certain interest-bearing deposits with no stated maturity dates are included in the interest-sensitivity table below. The balances allocated to the respective time periods represent an estimate of the total outstanding balance that has the potential to migrate through withdrawal or transfer to time deposits, thereby impacting the interest-sensitivity position of the Company. The estimates were derived from an independently prepared non-maturity deposit study for Wayne Bank which addressed the various deposit types and their pricing sensitivity to movements in market interest rates. The process involved analyzing correlations between product rates and market rates over a ten-year period. The Company believes the study provides pertinent data to support the assumptions used in modeling non-maturity deposits.

September 30, 2020

Rate Sensitivity Table

(dollars in thousands)



	3 Months		3-12 Months		1 to 3 Years		Over 3 Years		Total
Federal funds sold and interest-bearing deposits	$	100,120	$	—	$	446	$	—	$	100,566
Securities		16,857		46,968		63,721		69,890		197,436
Loans Receivable		230,672		292,186		432,765		459,039		1,414,662
Total RSA	$	347,649	$	339,154	$	496,932	$	528,929	$	1,712,664
Non-maturity interest-bearing deposits	$	65,905	$	65,335	$	173,554	$	303,715	$	608,509
Time Deposits		141,240		228,732		125,344		39,861		535,177
Borrowings		18,892		32,733		51,707		12,400		115,732
Total RSL	$	226,037	$	326,800	$	350,605	$	355,976	$	1,259,418
Interest Sensitivity Gap	$	121,612	$	12,354	$	146,327	$	172,953	$	453,246
Cumulative Gap		121,612		133,966		280,293		453,246
RSA/RSL-cumulative		153.80%		124.23%		131.03%		135.99%

December 31, 2019

Interest Sensitivity Gap	$	5,884	$	(82,454)	$	110,264	$	232,545	$	266,239
Cumulative Gap		5,884		(76,570)		33,694		266,239
RSA/RSL-cumulative		104.0%		82.8%		104.8%		130.6%

‎

Item 4. Controls and Procedures

The Company’s management evaluated, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, the effectiveness of the Company’s disclosure controls and procedures, as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

There were no changes in the Company’s internal control over financial reporting that occurred during the Company’s last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Part II. OTHER INFORMATION

Item 1. Legal Proceedings

Not applicable.

Item 1A. Risk Factors

The Global Outbreak of the COVID-19 Coronavirus May Pose Risks and Uncertainties to the Company’s Results of Operations, Financial Condition and Cash Flows

The outbreak of the COVID-19 pandemic has caused significant disruptions in the U.S. economy and has created disruption within the markets where the Company primarily operates. While there has been no material impact to the Company’s operations, the COVID-19 pandemic could potentially create a business continuity issue for the Company. If the global response to contain COVID-19 escalates further or is unsuccessful, the Company could experience a material adverse effect on its business, financial condition, results of operations and cash flows.

Congress, the President, and the Federal Reserve have taken actions to help with the economic fallout. The Coronavirus Aid, Relief and Economic Security (“CARES”) Act was signed into law at the end of March 2020 as a $2 trillion legislative package. The goal of the CARES Act is to prevent a severe economic downturn through various measures, including direct financial aid to American families and economic stimulus to significantly impacted industry sectors. In addition to the general impact of COVID-19, certain provisions of the CARES Act as well as other recent legislative and regulatory relief efforts are expected to have a material impact on the Company’s operations.

Other than the foregoing, there have been no material changes in the risk factors affecting the Company that were identified in Item 1A of Part 1 of the Company’s Form 10-K for the fiscal year ended December 31, 2019.

‎

Item 2. Unregistered Sales of Equity Sales and Use of Proceeds

(a)Unregistered Sales of Equity Securities. Not Applicable.

(b)Use of Proceeds. Not Applicable

(c) Issuer Purchases of Equity Securities. Set forth below is information regarding the Company’s stock repurchases during the quarter ended September 30, 2020.


	Issuer Purchases of Equity Securities
							Maximum Number
					Total Number of		(or Approximate
	Total				Shares (or Units)		Dollar Value) of Shares
	Number		Average		Purchased as Part of		(or Units)
	of Shares		Price Paid		Publicly		that May Yet Be
	(or Units)		Per Share		Announced Plans		Purchased Under the
	Purchased		(or Unit)		or Programs *		Plans or Programs
July 1 – 31, 2020		—	$	—		—		127,565
August 1 – 31, 2020		—		—		—		127,565
September 1 – 30, 2020		—		—		—		127,565
Total		—	$	—		—		127,565

*On March 19, 2008, the Registrant announced its intention to repurchase up to 5% of its outstanding common stock (approximately 226,050 split-adjusted shares) in the open market. On November 10, 2011, the Registrant announced that the Company had increased the number of shares which may be repurchased under its open-market program to 5% of its currently outstanding shares, or approximately 270,600 split-adjusted shares. There is no expiration date for this plan.

Item 3. Defaults Upon Senior Securities

Not applicable

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

‎

Item 6. Exhibits



No.	Description
3(i)	Amended and Restated Articles of Incorporation of Norwood Financial Corp.⁽¹⁾
3(ii)	Bylaws of Norwood Financial Corp.
4.0	Specimen Stock Certificate of Norwood Financial Corp.⁽²⁾
10.1	Employment Agreement with Lewis J. Critelli ⁽³⁾
10.2	Change in Control Severance Agreement with William S. Lance⁽³⁾
10.3	Change in Control Severance Agreement with Robert J. Mancuso⁽⁴⁾
10.4	Salary Continuation Agreement between the Bank and William W. Davis, Jr. ⁽⁵⁾
10.5	Amended and Restated Salary Continuation Agreement, dated September 1, 2017, between the Bank and Lewis J. Critelli ⁽⁶⁾
10.6	Salary Continuation Agreement between the Bank and John H. Sanders ⁽⁷⁾
10.7	2006 Stock Option Plan ⁽⁸⁾
10.8	First and Second Amendments to Salary Continuation Agreement with William W. Davis, Jr. ⁽⁹⁾
10.9	First and Second Amendments to Salary Continuation Agreement with John H. Sanders ⁽⁹⁾
10.10	Change In Control Severance Agreement with James F. Burke⁽¹⁰⁾
10.11	2014 Equity Incentive Plan, as amended⁽¹¹⁾
10.12	Addendum to Change in Control Severance Agreement with William S. Lance ⁽¹²⁾
10.13	Salary Continuation Agreement, dated September 1, 2017, between Wayne Bank and William S. Lance ⁽⁶⁾
10.14	Salary Continuation Agreement, dated September 1, 2017, between Wayne Bank and Robert J. Mancuso ⁽⁶⁾
10.15	Salary Continuation Agreement, dated September 1, 2017, between Wayne Bank and James F. Burke ⁽⁶⁾
10.16	Change-In-Control Severance Agreement, dated January 16, 2018, by and among Norwood Financial Corp., Wayne Bank, and John F. Carmody⁽¹³⁾
10.17	Addendum, dated January 16, 2018, to Change-In-Control Severance Agreement, dated March 2, 2010, by and among Norwood Financial Corp., Wayne Bank and William S. Lance⁽¹³⁾
10.18	Addendum, dated January 16, 2018, to Change-In-Control Severance Agreement, dated January 3, 2013, by and among Norwood Financial Corp., Wayne Bank and Robert J. Mancuso⁽¹³⁾
31.1	Rule 13a-14(a)/15d-14(a) Certification of CEO
31.2	Rule 13a-14(a)/15d-14(a) Certification of CFO
32	Certification pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of Sarbanes Oxley Act of 2002
101	The following materials from the Company’s Form 10-Q for the quarter ended September 30, 2020, formatted in Inline XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets; (ii) Consolidated Statements of Income; (iii) Consolidated Statements of Comprehensive Income; (iv) Consolidated Statements of Changes in Stockholders’ Equity; (v) Consolidated Statements of Cash Flows; and (vi) Notes to Consolidated Financial Statements.
101.INS	Inline XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document)
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

(1)Incorporated by reference into this document from Exhibit 3(i) to the Registrant’s Form 10-K filed with the Commission on March 13, 2020.

(2)Incorporated herein by reference into this document from the identically numbered Exhibits to the Registrant’s Form 10, Registration Statement initially filed in paper with the Commission on April 29, 1996, Registration No. 0-28364.

(3)Incorporated by reference into this document from the identically numbered exhibits to the Registrant’s Form 10-K filed with the Commission on March 15, 2010.

(4)Incorporated by reference into this document from Exhibit 10.4 to the Registrant’s Form 10-K filed with the Commission on March 14, 2013, File No. 0-28364.

(5)Incorporated by reference to Exhibit 10.6 to the Registrant’s Form 10-K filed with the Commission on March 23, 2000.

(6)Incorporated by reference from the exhibits to the Current Report on Form 8-K filed with the Commission on September 5, 2017.

(7)Incorporated herein by reference to Exhibit 10.11 to the Registrant’s Form 10-K filed with the Commission on March 22, 2004.

(8)Incorporated by reference to this document from Exhibit 4.1 to Registrant’s Registration Statement on Form S-8 (File No. 333-134831) filed with the Commission on June 8, 2006.

(9)Incorporated herein by reference from Exhibit 10.1 and 10.5 to the Registrant’s Current Report on Form 8-K filed on April 4, 2006.

(10)Incorporated by reference from Exhibit 10.13 to the Registrant’s Form 10-Q filed with the Commission on November 7, 2013.

(11)Incorporated by reference to Exhibit 10.1 to Post-Effective No. 1 to the Registrant’s Registration Statement on Form S-8 (File No. 333-195643) filed with the Commission on May 4, 2018.

(12)Incorporated by reference to Exhibit 10.1 to Registrant’s Current Report on Form 8-K filed on February 18, 2015.

(13)Incorporated by reference into this document from the exhibits to the Registrant’s Current Report on Form 8-K filed with the Commission on January 16, 2018.

‎

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



		NORWOOD FINANCIAL CORP

Date: November 6, 2020	By:	/s/ Lewis J. Critelli
		Lewis J. Critelli
		President and Chief Executive Officer
		(Principal Executive Officer)


Date: November 6, 2020		/s/ William S. Lance
		William S. Lance
		Executive Vice President and
		Chief Financial Officer
		(Principal Financial Officer)

NORWOOD FINANCIAL CORP - Quarter Report: 2020 September (Form 10-Q)

Critical Accounting Policies